logo
HLA-G EXPRESSION PROTECTS PORCINE ENDOTHELIAL CELLS AGAINST NATURAL KILLER CELL MEDIATED XENOGENEIC CYTOTOXICITY.
BCL-Xl AUGMENTS T CELL SURVIVAL IN THE ABSENCE OF COSTIMULATION AND BLOCKS IMMUNOSUPPRESSION WITH CTLA4IG.
INCREASED INTRAGRAFT ANGIOTENSINOGEN GENE EXPRESSION IN POST-TRANSPLANT RECURRENT FSGS
A RANDOMISED, DOUBLE-BLIND, PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION.
Specific tolerance without demonstrable chimerism: an alternative paradigm
FAS LIGAND AND NK CELLS ARE IMPORTANT MEDIATORS OF LATE SKIN GRAFT REJECTION
LUNG ALLOGRAFT FUNCTION CORRELATES WITH THE PATHWAY OF DONOR ANTIGEN PRESENTATION: MAINTENANCE OF PERIPHERAL BLOOD DONOR CELLS AND RELEASE OF SOLUBLE HLA OF DONOR ORIGIN.
COMPREHENSIVE STATE LEGISLATION DRAMATICALLY INCREASES ORGAN DONATIONS AND TRANSPLANTATION
LONG-TERM EVALUATION OF TWO PROTOCOLS OF ELECTIVE CYCLOSPORIN WITHDRAWAL IN RENAL TRANSPLANT RECIPIENTS
CAN “AREA UNDER THE CURVE” BASED ON ABBREVIATED PHARMACOKINETICS BE USED FOR CYCLOSPORINE MICROEMULSION (NEORAL®) MONITORING IN KIDNEY TRANSPLANT RECEPIENTS?
A META-ANALYSIS TO ASSESS THE SAFETY AND TOLERABILITY OF TWO FORMULATIONS OF CYCLOSPORINE: SANDIMMUNE AND NEORAL
CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANT RECIPIENTS
RACE EFFECT IN CADAVER RENAL TRANSPLANTS INDUCED WITH FULL-DOSE CYCLOSPORINE IRRESPECTIVE OF THE PRESENCE OF DELAYED GRAFT FUNCTION
TACROLIMUS/“LOW-DOSE” MYCOPHENOLATE MOFETIL VS. MICRO-EMULSION CYCLOSPORINE/ “LOW-DOSE” MYCOPHENOLATE MOFETIL AFTER KIDNEY TRANSPLANTATION-1 YEAR FOLLOW-UP OF A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL.
PREVALENCE OF CHRONIC ALLOGRAFT NEPHROPATHY AND ANALYSIS OF PREDICTIVE FACTORS: RESULTS OF 2-YEAR PROTOCOL BIOPSIES FROM A U.S. MULTICENTER STUDY.
BIOEQUIVALENCE OF SANG-35 AND NEORAL FOR CYCLOSPORINE METABOLITES IN STABLE RENAL TRANSPLANT RECIPIENTS
FAILURE OF NON-COMPLIANCE TO PREDICT GRAFT SURVIVAL IN LRD RENAL TRANSPLANTATION: THE UNOS EXPERIENCE
PROFILES OF NON-COMPLIANCE IN PATIENTS WITH A FUNCTIONING RENAL TRANSPLANT- A MULTI CENTER STUDY
PROGNOSIS FOLLOWING PRIMARY RENAL ALLOGRAFT FAILURE
DECREASED NEPHRON MASS (NM) IS NOT ASSOCIATED WITH WORSENED RENAL SURVIVAL, FUNCTION OR PROTEINURIA IN LIVING DONOR (LD) RENAL TRANSPLANTS: A MODEL FOR FUTURE RENAL TRANSPLANTATION (RT)
DIMINISHED LEVELS OF DEHYDROEPIANDROSTERONESULFATE IN LONG-TERM RENAL TRANSPLANT PATIENTS ARE ASSOCIATED WITH POORER GRAFT FUNCTION
Kidney Transplantation in Older Patients with Renal Failure
PREDICTING OUTCOME IN THE ELDERLY RENAL TRANSPLANT RECIPIENT
FACTORS INFLUENCING THE OUTCOME OF TRANSPLANTATION (Tx) IN OLDER ESRD PATIENTS (PTS) I.E., 60 + YEARS
INTERFERON-GAMMA (IFNγ) IS CRITICAL FOR REGULATING THE PROLIFERATION OF ALLOANTIGEN-ACTIVATED T CELLS.
TWO DISTINCT FORMS OF T CELL ANERGY ARE INDUCED BY LACK OF COSTIMULATION VS. CELL DIVISION DURING PRIMARY ACTIVATION.
THE AT1A RECEPTOR FOR ANGIOTENSIN II MODULATES T CELL PROLIFERATION IN MIXED LYMPHOCYTE CULTURES.
EXAMINING INDIVIDUAL T CELLS DURING AN IN VIVO IMMUNE RESPONSE: HOW DOES CD28 SIGNALLING REGULATE RECRUITMENT AND EXPANSION?
VISUALIZATION OF ANTIGEN-SPECIFIC CD4+ T CELL-B CELL INTERACTION DURING A PRIMARY IMMUNE RESPONSEIN VIVO.
ANTIBODIES TO A NOVEL T CELL ANTIGEN, TIRC7, BLOCK SELECTIVELY TYP 1 BUT NOT TYP 2 T-CELL ACTIVATION AND PROLONGS ALLOGRAFT SURVIVAL
The Effect of Endothelium on Th1 and Th2 Lymphocyte Apoptosis
ALLOGRAFT REJECTION OF FAS AND FAS-L DEFICIENT KIDNEYS: LACK OF CORRELATION BETWEEN IMPROVED FUNCTION AND APOPTOSIS
ANTIGEN PAINTING TO A XENOGRAFTED HEART'S CONTENT: TH2 CYTOKINE-INDUCED CHANGES IN PROTEOGLYCAN EXPRESSION RESULT IN ENDOTHELIAL COATING BY HOST MHC CLASS I AND REGULATORS OF COMPLEMENT ACTIVATION.
CD4-Mediated Islet Xenograft Rejection Requires `Indirect Antigen Recognition
TRANSPLANT ARTERIOSCLEROSIS OF LONGTERM CARDIAC XENOGRAFTS IS BLOCKED BY INDUCTION OF HEMOXYGENASE.
COSTIMULATORY PATHWAYS ARE ACTIVE IN XENOGENEIC IMMUNE RESPONSES.
IN VIVO REJECTION OF PORCINE SKIN GRAFTS IS MEDIATED BY HUMAN CD4+ T LYMPHOCYTES.
ALTERED EXPRESSION OF RAT PERIPHERAL T-CELL RECEPTOR Vβ REPERTOIRE IN F344-to-B10 (RAT-TO-MOUSE) MIXED XENOGENEIC CHIMERAS
ROLE OF REGULATORY CELLS DEVELOPING IN PORCINE THYMUS GRAFTS IN TOLERANCE TO BOTH HOST AND DONOR ANTIGENS
PORCINE THYMUS SUPPORTS DEVELOPMENT OF FUNCTIONAL HUMANT T CELLS
Tacrolimus vs. Neoral® in combination with Mycophenolate Mofetil and low-dose steroids after Liver Transplantation
CLINICAL BENEFIT OF NEORAL DOSE MONITORING WITH CYCLOSPORINE 2-HOUR PEAK LEVELS COMPARED TO TROUGH LEVELS IN STABLE LIVER TRANSPLANT PATIENTS
CYCLOSPORINE 2 HOUR BLOOD LEVEL: AN EXCELLENT PREDICTOR OF THE AREA-UNDER-THE-CURVE IN LIVER TRANSPLANT PATIENTS TREATED WITH NEORAL
COMPARATIVE PHARMACOKINETICS OF SANG-35 CYCLOSPORINE VERSUS NEORAL™ IN STABLE ADULT LIVER TRANSPLANT RECIPIENTS.
MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY ON EFFICACY AND SAFETY OF MICROEMULSION CYCLOSPORINE VERSUS CONVENTIONAL CYCLOSPORINE IN PATIENTS RECEIVING PRIMARY ORTHOTOPIC LIVER ALLOGRAFTS
A randomized, double-blind study of Neoral vs. Sandimmune in primary liver transplant recipients with two year follow up.
THE CANADIAN PROGRAF IN LIVER TRANSPLANT TRIAL: THE ONE-YEAR COMPOSITE OUTCOME.
STEROID WITHDRAWAL IS SAFE AND FEASIBLE IN STABLE LIVER TRANSPLANT RECIPIENTS.
ACUTE REJECTION IS MORE COMMON IN BLACK LIVER TRANSPLANT RECIPIENTS.
QUALITY OF LIFE OF CHILDREN POST TRANSPLANTATION COMPARED TO CHILDREN ON DIALYSIS.
THE EFFECT OF DIFFERENT IMMUNOSUPPRESSION THERAPY ON ERYTHROPOIETIN PRODUCTION IN RENAL TRANSPLANTATION
THE IMPACT OF DONOR SOURCE, PRE OPERATIVE IMMUNOTHERAPY AND PROPHYLACTIC ANTIBODY THERAPY ON FIRST REJECTION EPISODES IN CHILDREN.
HUMANIZED MONOCLONAL ANTI INTERLEUKIN-2 RECEPTOR (IL-2R) ANTIBODY DACLIZUMAB (ZENAPAX®) IN PEDIATRIC (Ped) RENAL TRANSPLANTATION (Tx)
POST TRANSPLANT DIABETES MELLITUS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)
RECURRENT REJECTION IN PEDIATRIC CARDIAC TRANSPLANTATION.
EXPERIMENTAL TRANSPLANTATION OF SIZE-REDUCED, ADULT KIDNEYS INTO PEDIATRIC RECIPIENTS
CYCLOSPORINE LEVEL CHANGES IN PEDIATRIC RENAL TRANSPLANT (TX) PATIENTS DURING GROWTH HORMONE THERAPY.
RESULTS OF SIMULTANEOUS AND SEQUENTIAL PEDIATRIC LIVER AND KIDNEY TRANSPLANTATION
INCIDENCE OF CMV INFECTIONS DURING DACLIZUMAB TREATMENT IN RENAL ALLOGRAFT PATIENTS
CLINICAL AND ECONOMIC IMPACT OF ORAL GANCICLOVIR PROPHYLAXIS OF CMV-DISEASE IN RENAL TRANSPLANTATION
Valaciclovir Reduces the Incidence of Cytomegalovirus Disease and Acute Graft Rejection in CMV-Seronegative Recipients of a Seropositive Cadaveric Renal Allograft
RISK FACTORS AND HUMAN HERPES VIRUS-8 (HHV8) DURING KAPOSI'S SARCOMA (KS) IN KIDNEY TRANSPLANT PATIENTS.
INTENSIVE SCREENING AND EVALUATION FOR HEPATITIS C VIRUS (HCV) IN THE PRETRANSPLANT ESRD PATIENT
THE LONG-TERM IMPACT OF HCV INFECTION IN RENAL ALLOGRAFT RECIPIENTS.
ORGAN DONATION AND ETHNICITY: PREDICTING SUPPORT FOR ORGAN DONATION AMONG ETHNIC MINORITIES.
ROLE OF THE PHYSICIAN IN EFFORTS TO BOOST ORGAN DONATION RATES.
EFFECTS OF BRAIN DEATH ON DONOR ORGAN QUALITY: ENDOTHELIAL CELL ACTIVATION AND PREDISPOSITION FOR ISCHEMIA/REPERFUSION DAMAGE IN TRANSPLANTATION
A PROSPECTIVE, RANDOMIZED MULTICENTER TRIAL COMPARING CELSIOR TO STANDARD CARDIAC PRESERVATION SOLUTIONS
THE MECHANISM OF CONCANAVALIN A IN RESUSCITATING TRANSPLANTED FALLING RAT HEARTS
PROTECTIVE ROLE OF NITRIC OXIDE IN ISCHEMIA AND REPERFUSION INJURY OF THE LIVER.
CHARACTERIZATION AND MANIPULATION OF T CELL RESPONSES TO A SINGLE DEFINED MINOR ALLOANTIGEN
Induction of autoimmunity after heart transplantation is a major component of the rejection process.
T CELL COSTIMULATORY BLOCKADE SUPPRESSES INDIRECT BETTER THAN DIRECT ALLOIMMUNE RESPONSES IN VIVO
ACUTE CD4-MEDIATED CARDIAC ALLOGRAFT REJECTION REQUIRES DONOR CLASS II MHC MOLECULES
Soluble MHC class I Molecules abrogate T Cell Function
GENETIC ENGINEERING OF IMMATURE DENDRITIC CELLS TO EXPRESS MAMMALIAN IL-10 ENHANCES THEIR IMMUNOGENICITY
ENHANCEMENT OF DENDRITIC CELL TOLEROGENICITY BY GENETIC MODIFICATION USING ADENOVIRAL VECTORS ENCODING cDNA FOR TGFβ1
DIRECT RECOGNITION OF MINIATURE SWINE ENDOTHELIAL CELLS BY HUMAN CD8 T CELLS INVOLVES BOTH XENOGENEIC SLA CLASS I MOLECULE AND ASSOCIATED PEPTIDES.
Transgenic Manipulation to Prevent Hyperacute Rejection of Xenografts: Triple Transgenic Mice and Pigs. Additive Effects of Complement Regulators and Suppression / Elimination of the α-Gal Epitope.
PROLONGED SURVIVAL OF HDAF TRANSGENIC PIG KIDNEYS IN PRIMATES
Anti-HLA antibodies do not recognize xenoantigens from DAF transgeneic pig kidneys
IDENTIFICATION OF HUMAN IMMUNOGLOBULIN GENES INVOLVED IN THE IMMUNE RESPONSE TO PIG TISSUES.
PROLONGATION OF HEART XENOGRAFT SURVIVAL IN A CONCORDANT HAMSTER TO RAT MODEL FOLLOWING THERAPY WITH A RATIONALLY DESIGNED IMMUNOSUPPRESSIVE PEPTIDE.
THE UNOS EXPANDED DONOR STUDY: RESULTS OF THE LIVER ANALYSIS.
THE UNITED STATES LIVER DONOR POPULATION IN THE 1990s: A DESCRIPTIVE, POPULATION-BASED COMPARATIVE STUDY
OUTCOME ANALYSIS OF MARGINAL DONOR LIVER GRAFTS TRANSPLANTED IN CRITICALLY ILL RECIPIENTS-THE UNOS REGISTRY DATA 1991-1995.
Incidence Of End-Stage Renal Failure Amongst Long-term Survival Of Primary Liver Transplant Recipients Under Tacrolimus: Adults and Children
Domino Liver Transplantation for Familial Amyloidotic Polyneuropathy: Optimal use of a Scarce Resource.
CHILD'S CLASS AT INITIAL EVALUATION CORRELATES WITH SURVIVAL TO LIVER TRANSPLANT
USE OF 2-D ECHO AND RIGHT HEART CATHETERIZATION FOR DIAGNOSIS OF PULMONARY HYPERTENSION IN PATIENTS EVALUATED FOR LIVER TRANSPLANTATION
OUTCOME OF RECURRENT AUTOINMUNE HEPATITIS AFTER LIVER TRANSPLANTATION
COMPONENTS OF CARE RESPONSIBLE FOR THE RISING COSTS INCURRED DURING THE PRE-TRANSPLANT PERIOD IN LIVER TRANSPLANT RECIPIENTS.
USEFULNESS OF URINE FIBRINOPEPTIDE A LEVELS IN DETECTING TRANSPLANT CORONARY ARTERIOPATHY
THE STATUS OF MICROVASCULAR ANTITHROMBIN AFTER EARLY FIBRIN DEPOSITION IS ASSOCIATED WITH OUTCOME IN CARDIAC TRANSPLANT RECIPIENTS.
ANTI-DONOR HLA ANTIBODIES ASSOCIATED WITH ALLOGRAFT ARTERIOPATHY DETECTED USING INTRAVASCULAR ULTRASOUND
EARLY VERSUS LATE ONSET VASCULAR REJECTION IN CARDIAC TRANSPLANTATION.
Cholesterol Lowering After Heart Transplantation is Associated with a Lower Incidence of Transplant Coronary Artery Disease.
Total Plasma Homocysteine Concentrations are Strongly Correlated with Whole Blood Cyclosporine Levels and Angiographic Coronary Artery Disease in Heart Transplant Patients.
EFFECTS OF SELECTIVE CD28:B7-1 BLOCKADE IN ACUTE CARDIAC ALLOGRAFT REJECTION
CD30 EXPRESSION IDENTIFIES A NOVEL ALLOREACTIVE T CELL SUBSET THAT IS FOUND WITHIN REJECTING ALLOGRAFTS
CD28 COSTIMULATION OF PROLIFERATION IN MURINE SPLENIC T CELLS IS SENSITIVE TO INHIBITION BY SP100030, A NOVEL T CELL-SPECIFIC DUAL INHIBITOR OF NF-κB AND AP-1
INHIBITION OF DIHYDROOROTATE DEHYDROGENASE (DHODH) IS THE MOLECULAR MECHANISM OF IMMUNOSUPPRESSION BY THE MALONONITRILAMIDES (MNAs) IN VIVO
MECHANISM OF ACTION OF CYCLOSPORINE A (CsA) AND TACROLIMUS (FK) ON CALCINEURIN (CN)
INNATE IMMUNITY IN SMALL BOWEL AND HEART TRANSPLANTATION
ACTIVATION OF THE IMMUNE SYSTEM IN PATIENTS AFTER CRYOPRESERVED HUMAN CARDIAC VALVE TRANSPLANTATION.
CYCLOSPORINE RESISTANT CD28 CO-STIMULATORY PATHWAY INHIBITION WITH CURCUMIN MAY BE DUE TO APOPTOSIS
EVALUATION OF IMPDH-ACTIVITY IN WHOLE BLOOD AND ISOLATED BLOOD CELL FRACTIONS FOR MONITORING OF CELL-CEPT®-MEDIATED IMMUNOSUPPRESSION.
GENERALIZED LOSS OF TcR BY GRAFT INFILTRATING T CELLS
TRANSDUCTION OF DENDRITIC CELLS WITH ADENOVIRAL VECTORS ENCODING CTLA4-Ig MARKEDLY REDUCES THEIR ALLOSTIMULATORY ACTIVITY
IMMUNOHISTOCHEMICAL ANALYSIS SUGGESTS THAT ACUTE REJECTION OF MURINE CARDIAC ALLOGRAFTS LACKING DONOR-TYPE APCs PROCEEDS VIA THE INDIRECT PATHWAY
DIFFERENTIAL USAGE OF THE CLASS II TRANSACTIVATOR (CIITA) PROMOTERSIN VIVO
STUDIES OF ALLOGRAFT TOLERANCE IN CLASS I AND CLASS II MHC DEFICIENT TRANSGENIC MICE WITHOUT IMMUNOSUPPRESSION
IDENTIFICATION OF CLASS I PEPTIDES INVOLVED IN THE INDIRECT PATHWAY OF ALLORECOGNITION
PASSENGER LEUKOCYTES FROM AN ALLOGENEIC HEART GRAFT CAN INDUCE LETHAL LYMPHOID APLASIA
MODULATION OF IMMUNE RESPONSES INDUCED BY GENE TRANSDUCED DENDRITIC CELLS
INFLUENCE OF CRYOPRESERVATION ON ANTIGEN EXPRESSION AND IMMUNOGENICITY OF HUMAN VASCULAR ENDOTHELIAL CELL
SIGNALS TRANSDUCED BY THE COMMON γ CHAIN OF CYTOKINE RECEPTORS ARE CRITICAL IN ALLOGRAFT REJECTION
Cytotoxic T-cells are diminished during allograft rejection in mice deficient of Stat1 (signal transducer + activator of transcription)
EARLY INTRAGRAFT EXPRESSION OF CHEMMOKINE GENES DURING ACUTE REJECTION OF ALLOGENEIC CARDIAC GRAFTS
RIBAVIRIN TREATMENT OF RECURRENT HEPATITIS C VIRUS (HCV) FOLLOWING LIVER TRANSPLANTATION: PROPOSED MECHANISM OF ACTION.
Chemokine Regulation of T Cell Entry Into Vascularized Allografts: A Central Role for Lymphotactin?
EFFECT OF THE LAZAROID U-74389G ON CHEMOKINE GENE EXPRESSION AND APOPTOSIS IN RENAL ISCHEMIA-REPERFUSION INJURY
A Novel NF-κB Enhancer Region Regulates Cytokine Induction Of The Human Inducible Nitric Oxide Synthase (iNOS) Gene Promoter
CMV Promoter Characteristics Determine Cytokine Sensitivity And Gene Expression In Adenovirus Mediated Gene Transfer
IN VIVO MIGRATION AND SURVIVAL OF DONOR-DERIVED DENDRITIC CELL PROGENITORS GENETICALLY MODIFIED USING AN ADENOVIRAL VECTOR ENCODING cDNA FOR TGFB1
ALLEVIATION OF GRAFT VERSUS HOST DISEASE BY INHIBITION OF TNFα PRODUCTION USING IMMUNOSUPPRESSIVE ALLOTRAP PEPTIDES
CONSTITUTIVE ACTIVATION OF CYTOKINE JAK/STAT SIGNALING PATHWAY PROTEINS IN EBV-TRANSFORMED B CELL LINES FROM PATIENTS WITH PTLD
DOWNMODULATION OF CXCR1 AND CXCR2 IN HUMAN NEUTROPHILS BY A MONOCLONAL ANTIBODY TO CD45RB.
ANALYSIS OF THE INTRAGRAFT CYTOKINE NETWORK IN HEART TRANSPLANT PATIENTS TREATED WITH AN ANTI-CD25 ANTIBODY
DIRECT EFFECT OF HUMAN TRANSFORMING GROWTH FACTOR-β1 ON ALBUMIN PERMEABILITY OF RAT GLOMERULI IN VITRO.
TOWARDS A GENOMIC ANALYSIS OF TRANSPLANT IMMUNOBIOLOGY AND RELATED PHENOMENA.
FLT-3 LIGAND INCREASES MICROCHIMERISM BUT CAN PREVENT THE THERAPEUTIC EFFECT OF DONOR BONE MARROW IN TRANSIENTLY IMMUNOSUPPRESSED CARDIAC ALLOGRAFT RECIPIENTS
Tolerance induction in rat transplantation models by anti-CD4 mAb is associated with intragraft upregulation of IL-4 - but intragraft overexpression of IL-4 is not sufficient for tolerance induction
Chemokine receptor expression in rejecting human liver transplants.
INTRAGRAFT EXPRESSION OF RANTES IS ASSOCIATED WITH GRANZYME B AND T CELL MEDIATED CYTOTOXICITY DURING REJECTION OF ALLOGENEIC SKIN GRAFTS
EXPRESSION OF iNOS IN ACUTE HUMAN RENAL ALLOGRAFT REJECTION.
URINARY CYTOKINE PATTERNS IN RENAL ALLOGRAFT RECIPIENTS
CD28:B7 BLOCKADE PREVENTS TRANSPLANT VASCULOPÁTHY AND MONONUCLEAR CELL INFILTRATION IN A FULLY ALLOGENEIC CARDIAC TRANSPLANT MODEL
RECIPIENT MESENCHYMAL CELLS INFILTRATE AND REMODEL MEDIAL AND ADVENTITIAL TISSUE IN THE RAT FEMORAL ARTERY ALLOGRAFT MODEL OF CHRONIC VASCULAR REJECTION
Prevention of Obliterative Airway Disease (OAD) without Immunosuppression in Heterotopic Rat Tracheal Allografts: Anastomosis of Recipient Trachea to Donor Trachea Enables Re-epithelialization of Allografts by Recipient Epithelium
LUNG EPITHELIUM-DERIVED IL-10 STIMULATES LUNG FIBROBLAST PROLIFERATION IN VITRO: IMPLICATIONS FOR THE PATHOGENESIS OF OBLITERATIVE BRONCHIOLITIS AFTER LUNG TRANSPLANTATION
CD4 and CD8 Contribute Independently to Vascular Thickening: Insights from CD4-knockout Recipients.
INDUCTION OF PROTEIN TYROSINE PHOSPHORYLATION BY TOXIN-CONJUGATED ANTI-CD3 ANTIBODIES.
COMBINED THERAPY WITH PRAVASTATIN (PVS) AND CYCLOSPORIN (CS) DECREASES ARTERIAL INTIMAL THICKENING IN A MODEL OF SEVERE VASCULAR IMMUNE INJURY
HEARTS LACKING DONOR-TYPE ANTIGEN PRESENTING CELLS DEVELOP CARDIAC ALLOGRAFT VASCULOPATHY
CYTOMEGALOVIRUS (CMV)-ACCELERATED TRANSPLANT VASCULAR SCLEROSIS(TVS): REQUIREMENT FOR ALLOREACTIVITY
CYTOKINES ASSOCIATED WITH MACROPHAGES BUT NOT T CELLS STIMULATE ENDOTHELIN-1 PEPTIDE SECRETION IN HUMAN ENDOTHELIAL CELLS AND GLOMERULAR MESANGIAL CELLS.
A MOLECULAR MECHANISM FOR THE DIRECT ANTIPROLIFERATIVE EFFECT OF MALONONITRILAMIDES (MNAs) ON VASCULAR SMOOTH MUSCLE CELLS.
COLD ISCHEMIA INDUCES CHRONIC TRANSPLANT DYSFUNCTION IN RAT RENAL TRANSPLANTS.
RAT ALLOGRAFT CORONARY VESSELS SWITCH TO SECRETING ANGIOGENIC PROTEINS POST-TRANSPLANTATION: POSSIBLE THERAPEUTIC ROLE OF PLATELET-ACTIVATING FACTOR (PAF) ANTAGONIST
DONOR-REACTIVE ALLOANTIBODY PRODUCTION CORRELATES WITH NEITHER ALLOGRAFT SURVIVAL NOR DEVELOPMENT OF TRANSPLANT VASCULAR SCLEROSIS (TVS)
Effect of antioxidant vitamins on transplant atherosclerosis in the Zucker rat model: Evidence for oxidative stress in the pathophysiology?
THE EFFECT OF IMMUNOSUPPRESSANTS ON THE DEVELOPMENT OF CHRONIC REJECTION IN RAT AORTAS
NITRIC OXIDE STIMULATES EXPRESSION OF MHC CLASS II HLA-DR MOLECULES IN CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS.
HEAT SHOCK PROTEIN EXPRESSION AND T-CELL REACTIVITY IN RAT CARDIAC ALLOGRAFTS UNDERGOING CHRONIC REJECTION
INJECTION OF PLASMA PROTEIN FRACTION FROM PATIENTS WITH FSGS CAUSES TRANSIENT PROTEINURIA IN RATS
TRANSVIVO ANALYSIS OF HUMAN DELAYED TYPE HYPERSENSITIVITY
IMMUNOHISTOCHEMICAL ANALYSIS OF WKY->F344 RAT SKIN ALLOGRAFTS AND CYTOKINE GENE EXPRESSION IN DRAINING LYMPH NODES: COMPARISON OF IMMUNOCOMPETENT ANIMALS TO ANIMALS TOLERIZED WITH DONOR-SPECIFIC LUNG ALLOGRAFTS
REVERSAL OF DIABETES IN STREPTOZOTOCIN-TREATED RATS BY INTRAMUSCULAR INJECTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS CONTAINING RAT PREPROINSULIN II GENE
MONITORING OF PHARMACODYNAMICS (PD), BUT NOT PHARMACOKINETICS (PK), DIFFERENTIATES THE RELATIVE IMMUNOSUPPRESSIVE POTENCIES OF LEFLUNOMIDE AND ITS MALONONITRILAMIDE (MNA) ANALOGS
REJECTION OF HUMAN ISLET GRAFTS BY HUMAN LEUKOCYTES IN NOD-SCID MICE.
USE OF ETA AND ETA +B RECEPTOR ANTAGONISTS IN ATTENUATING HEPATIC ISCHEMIA/ REPERFUSION INJURY.
INTERLEUKIN-1β STIMULATES ENDOTHELIN-1 GENE TRANSCRIPTION AND ENDOTHELIN CONVERTING ENZYME ACTIVITY IN HUMAN ENDOTHELIAL CELLS
ANTIBODIES ELUTED FROM ACUTELY REJECTED RENAL ALLOGRAFTS BIND TO AND ACTIVATE HUMAN ENDOTHELIAL CELLS.
FAS-MEDIATED CYTOTOXICITY IS NOT REQUIRED FOR RECURRENCE OF AUTOIMMUNE DIABETES IN NOD MICE
CONSTRUCTION OF A RECOMBINANT ADENOVIRUS VECTOR ENCODING Fas LIGAND WITH AN INDUCIBLE SYSTEM.
ANTI-HLA ANTIBODIES AND REJECTION TREATMENT MODALITY BOTH STRONGLY INFLUENCE GRAFT OUTCOME IN HIGH RISK CORNEAL TRANSPLANT RECEPIENTS.
CYTOPROTECTION INDUCED BY GENETIC MODIFICATION OF HUMAN ENDOTHELIAL CELLS(EC) DURING COLD PRESERVATION WITH AN ADENOVIRUS VECTOR ENCODING THE ANTI-APOPTOTIC Bcl-2 GENE.
ANALYSIS OF PASSENGER CELL COMPOSITION OF HUMAN FETAL PANCREAS: IMPLICATIONS FOR TRANSPLANTATION
Molecular Cloning, Expression and Characterization of Rhesus Macaque Fas Ligand cDNA
HIGHLY EFFICIENT, NONTOXIC GENETIC MODIFICATION OF HUMAN AND NON-HUMAN PRIMATE CD34+ STEM CELLS WITH A REPLICATION-DEFICIENT HERPES SIMPLEX VIRUS
An Immunologic Study of Liver Failure Patients Bridged with Hepatocyte Infusions
EXPRESSION OF A GPI-ANCHORED, SINGLE-CHAIN ANTIBODY SPECIFIC FOR A CELL DEATH SIGNALING DOMAIN OF HUMAN CLASS I MHC
Inactivation of the al-3 Galactosyltransferase Gene Protects Murine Hearts from Xenoantibody-dependent Human NK Cell / Monocyte Mediated Injury.
INDUCTION OF IMPDH ACTIVITY AFTER LONG-TERM TREATMENT WITH MYCOPHENOLATE MOFETIL
AN IMPROVED TECHNIQUE FOR ISOLATING PIG ISLETS: THE IMPORTANCE OF TENSEGRITY IN ISLET LONG TERM CULTURE VIABILITY
Incidence, Severity, and Outcome of Recurrent Hepatitis C is Similar in Patients Immunosuppressed with Neoral and Sandimmune
WITHDRAWAL OF PREDNISONE FROM ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C INFECTION
CLASS I AND II EXPRESSION AND CYTOKINE RELEASE AFTER ANTIGEN CHALLENGE IS ABNORMAL FOR HEPATITIS C INDIVIDUALS
Increased Risk Of Post-Transplant Lymphoproliferative Disease In Recipients Of Liver Transplants With Hepatitis C.
Quality of Life and Functional Status of Liver Transplant Recipients with Recurrent Hepatitis C Virus (HCV) Hepatitis.
INTRAHEPATIC BILE DUCT NECROSIS AS A CAUSE OF ALLOGRAFT FAILURE IN PATIENTS TRANSPLANTED FOR HEPATITIS C.
Hepatitis C Related Glomerulonephritis: A Growing Cause of Renal Failure After Liver Transplantation
Lamivudine Therapy : Prophylaxis and Rescue in Liver Transplant Patients
Long-term, Low Dose, Passive Immunoprophylaxis with HBIg Effectively Prevents Recurrence of Hepatitis B Infection after Liver Transplantation
Evolution of Prevention and Treatment of Post-Liver Transplant HBV Recurrence
ORTHOTOPIC LIVER TRANSPLANTATION (OLT) FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION.
Liver Transplantation for Hepatocellular Carcinoma
SURVIVING POSTTRANSPLANT LYMPHOMA IN THE LIVER TRANSPLANT RECIPIENT: CAUSE FOR OPTIMISM?
PRO-INFLAMMATORY AND TH-1 CYTOKINE PROFILES IN LIVER TRANSPLANT PATIENTS WHO REJECT AFTER OKT3 INDUCTION
HISTOPATHOLOGICAL FEATURES OF HEPATIC ALLOGRAFT REJECTION IN LIVING-RELATED LIVER TRANSPLANT RECIPIENTS
Comparison Of Quadruple Induction Including ATG Or IL-2 Receptor Antibody With FK506-Based Therapy After Liver Transplantation
CONVERSION FROM CYCLOSPORINE A TO MYCOPHENOLATE MOFETIL IN LIVER TRANSPLANT RECIPIENTS WITH RENAL FUNCTION IMPAIRMENT
RELATIONSHIP BETWEEN CALCINEURIN ACTIVITY AND CYCLOSPORINE PHARMACOKINETICS IN STABLE LIVER TRANSPLANT PATIENTS TREATED WITH NEORAL
COSTS OF CYCLOSPORINE (NEORAL®) AND TACROLIMUS (PROGRAF®) IN THE FIRST YEAR AFTER LIVER TRANSPLANTATION (OLT).
IMMUNIZATION, SCREENING FOR MALIGNANCY, AND HEALTH MAINTENANCE IN THE LIVER TRANSPLANT RECIPIENT.
SUCCESSFUL OUTCOME AFTER LIVER TRANSPLANTATION OF PATIENTS WITH“HIGH-RISK” PRETRANSPLANT PSYCHOSOCIAL EVALUATION.
QUALITY OF LIFE OF LIVER TRANSPLANT RECIPIENTS WITH ALCOHOLIC CIRRHOSIS COMPARED TO A NON-ALCOHOLIC SAMPLE.
ADAPTATION OF THE MAYO PRIMARY BILLARY CIRRHOSIS MODEL FOR MINIMUM LISTING CRITERIA FOR LIVER TRANSPLANT CADIDATES.
Complications of percutaneous liver biopsy in liver transplant Patients
DOES DIABETES MELLITUS INFLUENCE LIVER TRANSPLANT OUTCOMES?
OXALOSIS: STRATIFYING DISEASE SEVERITY AND THE ROLE OF ORGAN TRANSPLANTATION.
IS PRE-LIVER TRANSPLANT OBESITY A RISK FACTOR FOR POSTTRANSPLANT METABOLIC COMPLICATIONS?
MALNUTRITION AFFECTS LIVER TRANSPLANT OUTCOMES
KIDNEY TRANSPLANTATION AFTER LIVER TRANSPLANTATION. A SINGLE CENTER EXPERIENCE.
PILOT STUDY OF RECOMBINANT GROWTH HORMONE (GH) ADMINISTRATION FOLLOWING LIVER TRANSPLANTATION
SIGNIFICANCE OF PORTAL BLOOD FLOW DIVERSION IN AUXILIARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION FOR METABOLIC LIVER DISEASE
USE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A BRIDGE TO TRANSPLANTATION IN BUDDCHIARI SYNDROME.
REDUCTION OF REPERFUSION INJURY WITH PROSTACYCLIN 12 AFTER LIVER TRANSPLANTATION
FUNCTIONING HEPATOCYTE MASS IN LIVER ALLOGRAFTS ASSESSED BY99m Tc-GSALIVER SCINTIGRAPHY
An Economic Evaluation of Basiliximab (Simulect™) for the Prevention of Acute Rejection in Renal Allograft Recipients
THE COST OF CMV-DISEASE IN RENAL TRANSPLANTATION
PHARMACOKINETIC ANALYSIS OF MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN CADAVERIC RENAL TRANSPLANTATION
THE INCIDENCE AND COSTS OF STEROID-RELATED SIDE EFFECTS IN RENAL TRANSPLANTATION
LONG TERM RESOURCE UTILIZATION AND ECONOMIC OUTCOMES ANALYSIS AFTER BLADDER-DRAINED PANCREAS-KIDNEY TRANSPLANTATION (BD-SPK)
CLINICAL DETERMINANTS OF HEALTH RELATED QUALITY OF LIFE (HRQL) IN SOLID ORGAN TRANSPLANT RECIPIENTS
Reliability and Cost Effectiveness of Baseline Spirometry for Evaluating Pulmonary Function in Patients with Advanced Heart Failure Being Considered for Orthotopic Heart Transplantation.
THE COST OF REJECTION IN LIVER ALLOGRAFT RECIPIENTS
UTILIZATION OF A DONOR REGISTRY
DIAGNOSTIC ACCURACY OF CYTOTOXIC LYMPHOCYTE (CL) GENE EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES (PBL): CORRELATION WITH REJECTING RENAL ALLOGRAFTS
ANTI-DONOR ANTIBODY PRODUCTION AND DEVELOPMENT OF CHRONIC REJECTION IN RENAL TRANSPLANTS
CORRELATION BETWEEN BANFF CRITERIA AND OUTCOME AT 12 MONTHS FOLLOWING ACUTE REJECTION IN MULTICENTER RANDOMIZED TRIAL
PCNA +VE MONONUCLEAR CELLS IN A 6 MONTH (MO) PROTOCOL BIOPSY ASSOCIATE WITH LONG-TERM ALLOGRAFT FUNCTION.
CLINICOPATHOLOGIC FEATURES OF UNTREATED BORDERLINE CHANGES BY THE BANFF CRITERIA IN RENAL ALLOGRAFT BIOPSIES.
DETERMINANTS OF RENAL INSUFFICIENCY IN CHRONIC RENAL ALLOGRAFT REJECTION
DECREASED EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA (TGF-β) IN BIOPSIES WITH CHRONIC ALLOGRAFT NEPHROPATHY AFTER ONE YEAR OF 50% CYCLOSPORINE LEVEL REDUCTION AND MYCOPHENOLATE ADDITION
IS PERFORIN (P) EXPRESSION BY PERIPHERAL BLOOD LYMPHOCYTES (PBL) A PARAMETER OF ACUTE GRAFT REJECTION (AGR)?
THE PATHOPHYSIOLOGY OF ACUTE HUMAN RENAL ALLOGRAFT REJECTION
CYCLOSPORINE MONOTHERAPY IN PRIMARY LIVING DONOR RENAL ALLOGRAFT RECIPIENTS
IMPROVED OUTCOME OF STEROID WITHDRAWAL IN MYCOPHENOLATE MOFETIL TREATED PRIMARY CADAVERIC RENAL TRANSPLANT RECIPIENTS
STEROID WITHDRAWAL MAY COMPROMISE LONG TERM OUTCOME AFTER KIDNEY TRANSPLANTATION
A RANDOMISED STUDY ON THE EFFECTS OF CONVERSION OF CYCLOSPORINE/PREDNISONE TO CYCLOSPORINE/AZATHIOPRINE 6 MONTHS AFTER KIDNEY TRANSPLANTATION
TACROLIMUS THERAPY FOR REFRACTORY ACUTE RENAL ALLOGRAFT REJECTION: DIFFERENTIAL RESPONSES IN AFRICAN-AMERICANS AND CAUCASIANS.
CONVERSION FROM LIQUID TO SOLID SIROLIMUS FORMULATIONS IN STABLE RENAL ALLOGRAFT TRANSPLANT RECIPIENTS.
MULTIPLE-DOSE PHARMACOKINETICS OF THE IMMUNOSUPPRESSANT SDZ RAD IN STABLE RENAL TRANSPLANT PATIENTS
LONG-TERM RESULTS OF MIZORIBINE-TREATED RENAL TRANSPLANT RECIPIENTS-----A PROSPECTIVE, RANDOMIZED TRIAL OF MIZORIBINE AND AZATHIOPRINE UNDER CYCLOSPORINE-BASED IMMUNOSUPPRESSION.
WITHDRAWAL VS CONTINUOUS CYCLOSPORINE A (CsA) THERAPY IN KIDNEY TRANSPLANT RECIPIENTS OF HAPLOIDENTICAL DONORS.
Single Center Analysis of the Incidence of Acute Rejection in Cadaver Renal Allograft Recipients Induced with Low Dose OKT3 with and without Mycofenalate Mofetil (MMF)
BENEFITS OF PREEMPTIVE DOSE REDUCTION FOR SANDIMMUNE TO NEORAL CONVERSION IN STABLE RENAL TRANSPLANT RECIPIENTS
ATGAM™ LEVELS IN KIDNEY TRANSPLANT PATIENTS TREATED FOR ACUTE REJECTION
PREDNISONE-MYCOPHENOLATE MOFETIL DOUBLE THERAPY FOR CYCLOSPORINE A TOXICITY IN KIDNEY TRANSPLANTATION
A PHASE I STUDY: THE SIDE-EFFECT PROFILE OF AN INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE, ISIS 2302.
TACROLIMUS THERAPY FOR REFRACTORY ACUTE RENAL ALLOGRAFT REJECTION: A FOUR YEAR EXPERIENCE WITH AN AGGRESSIVE APPROACH
META-ANALYSIS OF TACROLIMUS AND MYCOPHENOLATE REFRACTORY REJECTION TRIALS IN RENAL TRANSPLANTATION
Pharmacokinetics of Tacrolimus (FK506) in Various Conditioning Renal Transplant Recipients
RANDOMISED TRIAL COMPARING CONVERSION OF MAINTENANCE TREATMENT WITH CICLOSPORINE AND PREDNISONE TO AZATHIOPRINE OR MYCOPHENOLATE MOFETIL WITH PREDNISONE ONE YEAR AFTER KIDNEY TRANSPLANTATION.
LACK OF BIOEQUIVALENCE OF TWO SANDIMMUNE® CYCLOSPORINE FORMULATIONS IN RENAL TRANSPLANT PATIENTS WHO ABSORB CYCLOSPORINE POORLY
EXTENDED FOLLOW-UP AND PHARMACOKINETIC ANALYSIS OF RENAL ALLOGRAFT RECIPIENTS TREATED WITH FK506 (FK) AND MYCOPHENOLATE MOFETIL (MMF) ASPRIMARY IMMUNOSUPPRESSION FOLLOWING KIDNEY TRANSPLANTATION
ANTIBODY INDUCTION IN THE CURRENT ERA
Variability in Cyclosporine exposure can be significantly reduced in stable kidney transplant patients.
CLINICAL IMPACT OF CHIMERIZATION ON THE IMMUNOGENICITY OF T-CELL ANTIGEN MONOCLONAL ANTIBODIES IN RENAL TRANSPLANTATION
DISPOSITION OF BASILIXIMAB, A CHIMERIC IL-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY, IN PEDIATRIC RENAL TRANSPLANT PATIENTS
NEORAL, CELLCEPT, PREDNISONE (NCP) VS NEORAL, IMURAN, PREDISONE (NIP) IN CADAVER KIDNEY TRANSPLANTATION.
A SERIES OF COMPARATIVE TRIALS BETWEEN SANG-35 AND OTHER CYCLOSPORINE(CsA) FORMULATIONS IN STABLE RENAL TRANSPLANT PATIENTS (Pts)
INDUCTION THERAPY WITH POLYCLONAL ATG IMPROVES LONG-TERM BUT NOT SHORT-TERM OUTCOME OF CADAVER RENAL ALLOGRAFTS
A LIMITED NUMBER OF HLA EPITOPES ARE RELATED TO ALLOGRAFT LOSS.
ASSIGNMENT OF CLASS I CROSS REACTIVE GROUP (CREG) BY DNA TYPING: LABORATORY DETECTION BY PCR-SSP OF CREG FOR MATCHING IN CLINICAL TRANSPLANTATION
EVIDENCE THAT A 36kD β2m ASSOCIATED sHLA IS DERIVED FROMβ2m-FREE HLA HEAVY CHAINS CLEAVED FROM ACTIVATED CELLS BY METALLOPROTEASE
MATCHING OF CROSS REACTIVE ANTIGEN GROUPS IN RENAL TRANSPLANTATION: NON UNOS, SINGLE CENTRE STUDY
ANALYSIS OF IMMUNOGENETIC FACTORS FOR THE LONGER WAITING TIME EXPERIENCED BY BLACK ESRD PATIENTS.
DETRIMENTAL INFLUENCE OF A HISTORIC POSITIVE BUT CURRENT NEGATIVE AHG T CELL IgG CROSSMATCH ON GRAFT OUTCOME IN CADAVERIC RENAL TRANSPLANTATION.
INFLUENCE OF A POSITIVE HISTORICAL ANTIHUMAN GLOBULIN CROSSMATCH ON LONG TERM KIDNEY ALLOGRAFT SURVIVAL.
Comparison of Antibody Screening Methods Using Flow Cytometry With Cells or Immobilized Purified HLA Antigens
BCL-2 DOES NOT PREVENT REJECTION OF ALLOGRAFTS IN A MOUSE MODEL OF HETEROTOPIC HEART TRANSPLANTATION.
THE HLA CLASS I DEFICIENT BURKITT LYMPHOMA CELL LINE DAUDI FAILS TO EXPRESS GPI-ANCHORED CELL SURFACE PROTEINS.
RAPID DEFINITION OF ANTIBODY SPECIFICITY BY ELISA
DONOR ACTION: AN INTERNATIONAL PROGRAMME TO ASSIST HOSPITALS INCREASE ORGAN DONATION
AN ALTERNATIVE APPROACH TO EVALUATING OPO PERFORMANCE
A CENTRALIZED HISTOCOMPATIBILITY LABORATORY ALLOWS REDUCTION IN COLD ISCHEMIA TIME AND OCCURRENCE OF ACUTE TUBULAR NECROSIS IN CADAVERIC RENAL TRANSPLANTS
Donor/Recipient traits impact long term renal allograft function independent of rejection.
RACE: A CRITICAL FACTOR IN ORGAN DONATION, PATIENT SELECTION, AND ORTHOTOPIC LIVER TRANSPLANTATION?
IONIZED CALCIUM CONCENTRATION IN MACHINE PERFUSATE PREDICTS EARLY GRAFT FUNCTION IN EXTENDED CRITERIA DONOR KIDNEYS
HIGH [K+] SOLUTIONS DO NOT PENETRATE THE HEPATIC PARENCHYMA AND ARE DETRIMENTAL FOR LIVER GRAFT SURVIVAL
INCREASED ENDOTHELIN-1 PRODUCTION DURING COLD ISCHEMIA IN STEATOTIC AND NONFUNCTIONAL HUMAN LIVER ALLOGRAFTS MAY INDICATE ENHANCED SUSCEPTIBILITY TO ISCHEMIA-REPERFUSION INJURY
SEVERITY OF ILLNESS AMONG LONG WAITING LIVER TRANSPLANT CANDIDATES IN AN ORGAN POOR REGION
A NOVEL HYDROXYL RADICAL SCAVENGER, NICARAVEN, ATTENUATES ISCHEMIA REPERFUSION INJURY OF THE LIVER
LONG-TERM GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION (LTX) IN THE UW-ERA: LATE EFFECTS OF COLD ISCHEMIA AND PRIMARY DSYFUNCTION
Gadolinium Chloride Induced Blockade of Kupffer Cells (KC) Ameliorates Ischemia/Reperfusion (I/R) Injury in the Steatotic Liver.
IN VIVO ISCHEMIA-REPERFUSION INJURED RAT HEARTS SUSTAIN LONG TERM PRESERVATION AND TRANSPLANTATION
IMPROVED MYOCARDIAL PRESERVATION WITH CELSIOR AND A MUTANT SUPEROXIDE DISMUTASE
DONOR DEMOGRAPHIC CHANGES AND TRANSPLANTABLE ORGANS
CONTINUED LOSS OF BONE DENSITY ONE YEAR POST KIDNEY TRANSPLANT DESPITE PREEMPTIVE THERAPY
Risk Factors for Steroid Induced Bone Disease in Renal Transplantation
THE INCIDENCE AND MANAGEMENT OF OSTEOPOROSIS, GOUT, AND AVASCULAR NECROSIS IN >20-YEAR RENAL ALLOGRAFT RECIPIENTS (LEVEL 5A) TREATED WITH PREDNISONE AND AZATHIOPRINE
PHARMACOLOGIC VARIABILITY OF EVERY OTHER DAY (QOD) GLUCOCORTICOID THERAPY IN RENAL TRANSPLANT RECIPIENTS (RTR)
NATIVE PERIPHERAL VASCULAR DISEASE CONTRIBUTES TO RENAL TRANSPLANT RENOVASCULAR DISEASE
Hyperhomocyst(e)inemia as an independent risk factor for cardiovascular disease in renal transplant recipients.
Perioperative cardiac morbidity in Renal Transplant Recipients: Incidence and Risk Factors.
PROSPECTIVE PRETRANSPLANT ULTRASOUND SCREENING IN 206 PATIENTS FOR ACQUIRED RENAL CYSTS AND RENAL CELL CARCINOMA.
PARADIGM LOST: IL-10 IS A SUPERIOR CORRELATE OF ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS COMPARED TO TH1 CYTOKINE IFN-γ.
SAFETY AND TOLERABILITY OF THE IMMUNOSUPRESSANT SDZ RAD IN STABLE RENAL TRANSPLANT RECIPIENTS
RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR Fc FUSION PROTEIN(TNFR:Fc) THERAPY IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING OKT3 INDUCTION THERAPY
USE OF PRE-TRANSPLANT MLC IMMUNOASSAY TO ESTIMATE THE RISK OF ACUTE REJECTION AFTER KIDNEY TRANSPLANT
ELISA SPOT DETECTION OF INTERFERON GAMMA AND INTERLEUKIN 5 PRODUCING CELLS AS A PREDICTIVE MARKER FOR RENAL ALLOGRAFT FAILURE
FAILURE OF DONOR SPECIFIC TRANSFUSION (DST) TO IMPROVE LONG TERM OUTCOME IN LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE: A 12-YEAR RETROSPECTIVE STUDY FROM SEOPF
ANTI-PHOSPHOLIPID ANTIBODY SYNDROME AND POST-TRANSPLANT RENAL THROMBOSIS
NATIONAL TRANSPLANTATION PREGNANCY REGISTRY: PREGNANCY OUTCOMES IN FEMALE KIDNEY RECIPIENTS TREATED WITH CYCLOSPORINE MICROEMULSION (NEORAL) OR TACROLIMUS VS. CYCLOSPORINE
C6 PRODUCED BY MACROPHAGES CONTRIBUTES TO CARDIAC ALLOGRAFT REJECTION
Alloimmune-mediated apoptosis during acute and chronic rejection of the transplanted heart
NOS2 induces apoptosis during acute cardiac rejection: Analysis of in vivo pathways in NOS2-knock out mice
ANALYSIS OF T CELL DEPENDENT NITRIC OXIDE PRODUCTION BY MURINE MACROPHAGES
IN VIVO IMAGING OF APOPTOSIS DURING CARDIAC ALLOGRAFT REJECTION USING RADIOLABELED ANNEXIN V
Role of TGFβ1 and IL-10 in the immunoregulatory effect of allogeneic CD34+ cells
TGF-β MIMICS AND ANTI-TGF-β REVERSES THE FIBROGENIC AND NEPHROTOXIC EFFECTS OF CYCLOSPORINE
GENETICALLY MODIFIED CD34+ CELLS AS VECTORS FOR IN VIVO GENE DELIVERY TO AREAS OF ANGIOGENESIS.
CYTOPROTECTION OF PANCREATIC ISLETS (PI) IN CULTURE BY GENETIC MODIFICATION WITH THE ANTI-APOPTOTIC Bcl-2 GENE.
REDUCTION OF ISCHEMIA/REPERFUSION INJURY TO THE LIVER BY GENE TRANSFER OF THE ANTI-APOPTOTIC Bcl-2 GENE WITH AN ADENOVIRAL VECTOR.
GENETIC MODIFICATION OF LIVER GRAFTS WITH AN ADENOVIRUS ENCODING Bcl-2 FOR IMPROVED ORGAN PRESERVATION.
Donor Resting B Cells Induce Indefinite Prolongation of Fully Allogeneic Cardiac Grafts When Delivered with Anti-IgD Monoclonal Antibody
MYCOPHENOLATE SUPPRESSES NITRIC OXIDE (NO) PRODUCTION DURING ANTILYMPHOCYTE THERAPY IN RENAL ALLOGRAFT RECIPIENTS
Blockade of CD40L/CD40 costimulatory pathway in a DST pre-sensitization model of islet allograft leads to a state of allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or
ENHANCEMENT OF IMMATURE DENDRITIC CELL TOLEROGENICITY BY ADMINISTRATION OF ANTI-CD40 LIGAND mAb IS ASSOCIATED WITH T CELL APOPTOSIS NOT INHIBITION OF B7 MOLECULE EXPRESSION
HIGH LEVELS OF STABLE MULTI-LINEAGE HEMATOPOIETIC CHIMERISM AND DONOR-SPECIFIC ALLOGENEIC SKIN GRAFT TOLERANCE WITH T-CELL COSTIMULATORY BLOCKADE
CREATION OF MIXED BONE MARROW CHIMERA BY SUB-LETHAL IRRADIATION AND COMBINED BLOCKADE OF CD28/B7 AND CD40/CD40L COSTIMULATORY PATHWAYS
CTLA4Ig REDUCES THE DOSE OF RADIATION REQUIRED TO ACHIEVE MIXED HEMATOPOIETIC CHIMERISM AND DONOR-SPECIFIC TRANSPLANTATION TOLERANCE IN RATS
SHORT- AND LONG-TERM ENGRAFTMENT-POTENTIAL OF MOBILIZED FACILITATING CELLS AND HEMATOPOIETIC STEM CELLS ACROSS MHC-BARRIERS.
ALLOGENEIC THYMOKIDNEY TRANSPLANTS INDUCES STABLE TOLERANCE IN MINIATURE SWINE
LONG TERM (10 MONTH) PIG ISLET XENOGRAFT (PIX) TOLERANCE USING MEASURED-TOTAL LYMPHOID IRRADIATION, SPLENECTOMY SHORT TERM RABBIT ANTITHYMOCYTE GLOBULIN AND DEOXYSPERGUALIN WITHOUT CHRONIC IMMUNOSUPPRESSION
REVERSAL OF NATURALLY OCCURRING INSULINOPENIC DIABETES AND INDUCTION OF ISOLATED ISLET XENOGRAFT TOLERANCE IN A PRE-CLINICAL STUDY
Tolerability and Side Effects of Anti-CD3 Immunotoxin (αCD3-IT) in Preclinical Testing in Kidney Allograft Recipients
Early systemic immunologic factors associated with induction of long term renal allograft tolerance without maintenance immunosuppressive drugs
EVIDENCE FOR RENAL TRANSPLANT TOLERANCE TO NON-INHERITED MATERNAL ANTIGENS(NIMA) IN 1 HLA-HAPLOTYPE MATCHED SIBLINGS: A MULTICENTER STUDY
ARE WEDGE BIOPSIES OF CADAVERIC KIDNEYS OBTAINED AT PROCUREMENT RELIABLE?
TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS
RISK FACTORS FOR RENAL ALLOGRAFT SURVIVAL FROM PEDIATRIC CADAVER DONORS
IS THERE A DIFFERENCE IN THE QUALITY OF KIDNEYS THAT ARE OFFERED FOR PAYBACK COMPARED TO NON-PAYBACK KIDNEYS?
EXCHANGE DONOR PROGRAM IN KIDNEY TRANSPLANTATION
EVALUATION OF RENAL FUNCTION IN POTENTIAL LIVING RELATED DONORS (LRD).
A COMPARATIVE STUDY OF CONVENTIONAL AND MINIMALLY INVASIVE OPEN LIVING DONOR NEPHRECTOMY
Laparoscopic vs. Open Live Donor Nephrectomy: A Multivariate Patient Outcomes Analysis
A 12 YEAR SINGLE CENTER EXPERIENCE OF 100 RENAL TRANSPLANTS WITH NON-HEARTBEATING DONOR GRAFTS
PROSTAGLANDIN E1 IMPROVES PERFUSION CHARACTERISTICS AND EARLY GRAFT FUNCTION IN EXTENDED CRITERIA DONOR KIDNEYS
A New Technique for Direct Analysis of Reperfusion Mechanisms after Lung Ischemia
CLINICAL AND ECONOMIC IMPLICATIONS OF USING ANTI-HBc-POSITIVE DONORS FOR LIVER TRANSPLANTATION
CLINICAL IMPACT OF TITRATED WITHDRAWAL OF IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
PEDIATRIC LIVER TRANSPLANTATION : FROM THE FULL-SIZE LIVER GRAFT(FS) TO THE REDUCED (RED), SPLIT AND LIVING RELATED LIVER TRANSPLANTATION(LRLT).
LIVER TRANSPLANTATION AS TREATMENT FOR HEPATOCELLULAR MALIGNANCY IN CHILDREN.
VARIABLES AFFECTING THE RISK OF CMV INFECTION OR SEROCONVERSION IN THE UNEXPOSED PEDIATRIC LIVER TRANSPLANT RECIPIENT
STRATEGY TO REDUCE THE INCIDENCE AND MORTALITY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER LIVER TRANSPLANTATION IN CHILDREN
SURVIVAL AND MORBIDITY AFTER FULL SIZE, PARTIAL AND SPLIT LIVER TRANSPLANTATION IN CHILDREN
LONG-TERM OUTCOME AND COMPLICATIONS OF LIVING RELATED LIVER TRANSPLANTATION (LRLT) IN CHILDREN WITH INTRAPULMONARY SHUNTING
INCIDENCE, MANAGEMENT, AND OUTCOME OF SERIOUS PANCREATITIS FOLLOWING PEDIATRIC LIVER TRANSPLANTATION
Transplantation of Pediatric Patients with Fulminant Hepatic Failure: Improved Survival with Utilization of Segmental Allografts from Live Donors.
AN ANALYSIS OF PRETRANSPLANT VARIABLES ASSOCIATED WITH LONG-TERM GRAFT OUTCOME IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS THERAPY
Primary Liver Transplantation in children under Tacrolimus:3 to 8 years actual follow-up
Conversion of pediatric liver allograft recipients from Cyclosporin to Tacrolimus based immunosuppression: 4 to 8 years follow-up.
INTRARENAL EXPRESSION OF CYTOTOXIC ATTACK MOLECULES DURING ACUTE REJECTION OF RENAL ALLOGRAFTS IN PEDIATRIC RECIPIENTS
A MULTIVARIATE ANALYSIS OF THE CAUSES OF RACIAL DISPARITIES IN THE LIVING RELATED DONOR RENAL TRANSPLANT POPULATION: THE UNOS EXPERIENCE
INTERRUPTION OF CD40/CD40L CO-STIMULATION ALTERS INTRAGRAFT CHEMOKINE EXPRESSION: REJECTION IS LINKED TO CXCR3+ CELLS AND LIGANDS IP-10 AND MIG WHEREAS LONG-TERM SURVIVAL IS ASSOCIATED WITH THEIR SUPPRESSION AND INFILTRATIOIN BY CCR2+ CELLS.
ELIMINATION OF ANTIBODY RESPONSES INHIBITS ACUTE AND CHRONIC CARDIAC ALLOGRAFT REJECTION IN MICE.
DELAYED GRAFT FUNCTION PREDICTS LONG-TERM KIDNEY GRAFT SURVIVAL INDEPENDENT OF EARLY ACUTE REJECTION OR DISCHARGE CREATININE
Expression of LFA1 in biopsies of kidney recipients treated with an anti-LFA1 monoclonal antibody. Correlations with delayed graft function
THE RATE OF DECLINE IN RENAL FUNCTION IN CHRONIC ALLOGRAFT REJECTION(FIBROSIS) CAN BE PREDICTED BY INTRATUBULAR LEVELS OF TRANSFORMING GROWTH FACTOR BETA (TGFβ)
DIABETES MELLITUS WITH NEORAL (CYCLOSPORINE) VS. PROGRAF (TACROLIMUS) BASED REGIMENS AFTER KIDNEY TRANSPLANT
LATE ONSET POST-TRANSPLANT DIABETES IN HYPERLIPIDEMIC RENAL TRANSPLANT RECIPIENTS: PREDICTIVE VALUE FOR GLUCOSE AREA-UNDER-THE-CURVE (GLU-AUC) AND NATURAL HISTORY OF INSULIN RESPONSE TO MEAL CHALLENGE
DE NOVO INSULIN-DEPENDENT DIABETES MELLITUS IN LIVING KIDNEY TRANSPLANT RECIPIENTS UNDER TACROLIMUS IMMUNOSUPPRESSION.
SUCCESFUL TRANSPLANTATION WITHOUT RECURRENCE IN HEMOLYTIC UREMIC SYNDROME OMITTING CALCINEURIN INHIBITORS FOR IMMUNOSUPPRESSION
INFERIOR OUTCOME OF CADAVERIC KIDNEYS PRESERVED ≥24 HRS IN HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) SOLUTION
CLINICAL EXPERIENCE WITH AUTOLOGOUS AND ALLOGENEIC PANCREATIC ISLET TRANSPLANTATION
A MULTIVARIATE ANALYSIS OF MATCHING AND GRAFT SURVIVAL IN SPK TRANSPLANTATION: THE UNOS EXPERIENCE
FATE OF TYPE I DIABETICS WHOSE GRAFTS FAIL AFTER KIDNEY OR SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS
THE IMPACT OF HYPOALBUMINEMIA IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANT RECIPIENTS
ESTIMATING QUALITY OF LIFE IN UREMIC IDDM PATIENTS FOR THE PURPOSE OF MEDICAL DECISION ANALYSIS
POSTTRANSPLANT INFECTION IN ENTERIC VS BLADDER-DRAINED SIMULTANEOUS PANCREAS-KIDNEY (SPK) TRANSPLANTS
EFFECT OF COMBINED KIDNEY-PANCREAS TRANSPLANT ON THE LIPID PROFILE: ONE YEAR FOLLOW-UP
Pretransplantation Insulin Dose As An Indicator Of Hyperglycemia Following Pancreatic Transplantation
ALLOGRAFT PANCREATECTOMY AFTER PANCREAS TRANSPLANTATION: A COMPARISON OF SYSTEMIC-BLADDER VERSUS PORTAL-ENTERIC DRAINAGE.
PRELIMINARY EXPERIENCE WITH MIDODRINE (PROAMATINE) IN KIDNEY/PANCREAS TRANSPLANT PATIENTS EXPERIENCING ORTHOSTATIC HYPOTENSION
MRI IS SUPERIOR TO ANGIOGRAPHY FOR LIVING RELATED SIMULTANEOUS PANCREAS AND KIDNEY (SPK) DONATION.
MYOFIBROBLASTS EXPRESSING α-SMOOTH MUSCLE ACTIN IN GRAFT PANCREATITIS.
TWO DONOR POLYMORPHIC AMINO ACIDS (S77 AND N80) FORM A TOLEROGENIC EPITOPE THAT INDUCES DONOR-SPECIFIC TRANSPLANTATION TOLERANCE IN RATS
IN VITRO AND IN VIVO IMMMUNOMODULATORY EFFECTS OF RDP 1258, A NOVEL SYNTHETIC PEPTIDE
Prolongation of Rat Allograft Survival Following Therapy with Rationally Designed Immunosuppressive Peptides: Analysis of the Mechanism of Action.
A MURINE TRANSGENIC MODEL OF HUMAN CLASS I MHC-MEDIATED PROGRAMMED CELL DEATH
ANTI-MHC CLASS II MABS SUPPRESS ALLOGENEIC RESPONSES IN SOLID ORGAN TRANSPLANTATION IN MICE AND PRIMATES
PROPHYLAXIS OF RENAL ALLOGRAFTS FROM REJECTION BY FTY720 IN CYNOMOLGUS MONKEYS TREATED WITH SUBTHERAPEUTIC DOSES OF CYCLOSPORINE
PHARMACOKINETICS OF IV ADMINISTERED MURINE ANTI-HUMAN B7.1 AND MURINE ANTI-HUMAN B7.2 IN CYNOMOLGUS MONKEYS
EFFECTS OF ANTI-CD2 MONOCLONAL ANTIBODY : CD2 AND CD95-MEDIATED APOPTOSIS OF HUMAN PERIPHERAL T CELLS.
CHRONIC CARDIAC ALLOGRAFT REJECTION IS INDEPENDENT OF DONOR MHC CLASS II ANTIGENS
CHARACTERIZATION OF MHC ALLOPEPTIDE REACTIVE T CELL CLONES FROM HUMAN RENAL ALLOGRAFT RECIPIENTS
ALLOANTIBODIES ARE NOT REQUIRED FOR DEVELOPMENT OF TRANSPLANT VASCULAR SCLEROSIS
Evidence Against the Role of Th1 in the Development of Chronic Cardiac Allograft Rejection
IL-10 and IFN-γ Mediate Cardiac Allograft Vascular Changes: Insights from IL-10 Knockout Mice
TRANSFORMING GROWTH FACTOR BETA PLAYS A CRITICAL ROLE IN CHRONIC REJECTION
Immune sources of TGF-βI protect against graft vasculopathy: Graft vascular remodeling in TGF-βI-deficient mice
ANTI-PROLIFERATIVE EFFECTS OF PRAVASTATIN (PVS) AND CYCLOSPORIN (CS) ON VASCULAR SMOOTH MUSCLE CELLS (VSMC) - IS INHIBITION OF RAS ACTIVITY THE MECHANISM?
Disruption of IL-4 responses in STAT6-knock out mice does not alter graft vasculopathy
Contribution of IFN-γ to acute allograft failure in murine cardiac transplants: Role in vascular thrombosis
IL-2 + INTERFERON-γ DOUBLE KNOCKOUT MICE REJECT HETEROTOPIC CARDIAC ALLOGRAFTS.
TYPE 2 IMMUNE DEVIATION DIFFERENTIALLY AFFECTS ALLOREACTIVE CD4+ AND CD8+ T CELLS BUT DOES NOT ALTER THEIR ABILITY TO MEDIATE SKIN GRAFT REJECTION
IMMUNE NONRESPONSIVENESS TO CARDIAC ALLOGRAFTS BY INTRATHYMIC INOCULATION OF DONOR CLASS I ALLOPEPTIDES IS ASSOCIATED WITH HIGH LEVELS OF TRANSCRIPTS FOR TH2 CYTOKINES IN THE GRAFT
PROLONGATION OF ORGAN ALLOGRAFT SURVIVAL BY SYSTEMIC ANTI-IL-10 ANTIBODY ADMINISTRATION IS MEDIATED BY B CELL SUPPRESSION
IDENTIFICATION OF SEQUENCES INVOLVED IN INTERNALIZATION AND DEGRADATION OF THE COMMON CYTOKINE RECEPTOR γC CHAIN
RAPAMYCIN (RAPA) ENHANCES TRANSFORMING GROWTH FACTOR BETA(TGF-β1) EXPRESSION IN IMMORTALIZED RAT PROXIMAL TUBULES CELLS(IRPTC).
THE EFFICACY OF ORAL STEROID PULSE FOR THE TREATMENT OF ASYMPTOMATIC MODERATE CARDIAC ALLOGRAFT REJECTION.
The Meaning of Mild Rejection During Corticosteroid Weaning in Heart Transplant Recipients.
Intention to Transplant Survival. Is This a More Accurate Predictor of the Survival Probabilities of Patients After They Are Accepted for Cardiac Transplantation?
HEPATITIS C REGISTRY REPORT: INTERMEDIATE FOLLOW-UP AFTER CARDIAC TRANSPLANTATION
COMBINED HEART AND KIDNEY TRANSPLANTATION USING A SINGLE DONOR
IMPACT OF GENDER MISMATCH ON THE OUTCOME OF CARDIAC TRANSPLANTATION.
Risk Factors for Malignancies in Heart Transplant Recipients.
Increased Morbidity in Insulin-Dependent Diabetic Patients Long-Term After Heart Transplantation.
HEART TRANSPLANTATION IN THE OLDER RECIPIENT: INITIAL RESULTS OF A SINGLE CENTER EXPERIENCE
LONG TERM MORTALITY AND MORBIDITY WITH THE USE OF OLDER DONORS IN CARDIAC TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
IMMEDIATE POST-TRANSPLANT MYOCYTE NECROSIS DETECTED BY ELEVATED SERUM LEVELS OF TROPONIN I IS ASSOCIATED WITH AN ADVERSE LONG TERM GRAFTOUTCOME.
REJECTION PATTERN OF SIMULTANEOUSLY TRANSPLANTED CARDIAC AND SKELETAL MUSCLE IN A RAT MODEL.
PRE-EMPTIVE TREATMENT WITH INTRAVENOUS GANCICLOVIR AND SERIAL PCR MONITORING FOR EBV REDUCES THE RISK OF LPD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
INCREASED HEPATITIS C VIREMIA IN CHOLESTATIC HEPATITIS C FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION. IS THE PATHOGENECITY OF THE SYNDROME RELATED TO VIRAL CYTOPATHIC MECHANISMS?
HEPATITIS C INFECTION IN PATIENTS UNDERGOING HEPATIC RETRANSPLANTION(ReTx).
QUANTITATION OF HEPATITIS C VIRUS RNA IN LIVER TISSUE OF ALLOGRAFTS: CORRELATION WITH HISTOLOGIC FEATURES AND LIVER FUNCTION TESTS.
OUTCOMES COMPARISON OF PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATITIS B AND HEPATITIS C
Cytomegalovirous infection in liver transplant recipients; detection of early antigenemia (pp65) in peripheral blood leukocytes and preemptive therapy.
CMV GENOTYPIC VARIABILITY AFFECTS RATE OF REJECTION BUT NOT SURVIVAL AFTER LIVER TRANSPLANTATION.
TUMOR NECROSIS FACTOR (TNF) GENETIC POLYMORPHISMS CORRELATE WITH INFECTIONS AFTER LIVER TRANSPLANTATION
LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION.
A RANDOMISED STUDY OF CONVENTIONAL VS LOW DOSE CYCLOSPORINE IN RENAL TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE, MYCOPHENOLATE MOFETIL AND PREDNISONE.
TRANSPLANTATION WITHOUT MAINTENANCE CORTICOSTEROIDS IN 1-HAPLOTYPE AND 2-HAPLOTYPE MATCHED LIVING RELATED RENAL TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL AND CYCLOSPORINE
A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER TRIAL COMPARING TWO CORTICOSTEROID REGIMENS IN COMBINATION WITH MYCOPHENOLATE MOFETIL (MMF) AND CYCLOSPORINE (CYA) IN RENAL TRANSPLANT RECIPIENTS
CONVERSION OF CYCLOSPORINE (NEORAL®; CsA) TO MYCOPHENOLATE MOFETIL(CELLCEPT®; MMF) IN STABLE RENAL TRANSPLANT PATIENTS
DONOR BONE MARROW, CHIMERISM, AND KIDNEY TRANSPLANTATION.
TRANSPLANTATION OF PEDIATRIC ENBLOC CADAVER KIDNEYS INTO ADULT RECIPIENTS
ARE TWO KIDNEYS BETTER THAN ONE? OUTCOME IN SINGLE (SNGL) VS EN BLOC (EB) AND DUAL (DU) KIDNEY TRANSPLANTS (TXP)
Excellent Kidney Transplant Outcome using Non-heart Beating Donor Kidneys.
THE FATE OF 359 RENAL ALLOGRAFTS HARVESTED FROM NON-HEART BEATING UNCONTROLLED CADAVERS AT A SINGLE CENTER
OPEN VERSUS LAPROSCOPIC DONOR NEPHRECTOMY: IS THERE A DIFFERENCE IN RECIPIENT RENAL FUNCTION?
LAPAROSCOPIC LIVE DONOR NEPHRECTOMY: THE RECIPIENT
DO HUMAN ENDOTHELIAL CELLS UTILIZE THE CD28/B7 PATHWAY TO COSTIMULATE CD4+ T CELL ACTIVATION?
ALLOGENEIC ENDOTHELIUM INDUCES B7-2 EXPRESSION IN TRANSMIGRATING LEUKOCYTES.
THE ROLE OF α4 INTEGRIN/FIBRONECTIN INTERACTIONS IN ALLOSPECIFIC CYTOTOXIC T CELL ACTIVATION AND HOMING-INITIAL STUDIES IN THE 2C T-CELL RECEPTOR TRANSGENIC.
IL-17 PROMOTES DENDRITIC CELL MATURATION AND ALLOIMMUNE REACTIVITY: INHIBITORY EFFECTS OF IL-17R:Fc
INTERFERON-GAMMA (IFNγ) IS REQUIRED FOR LONGTERM ALLOGRAFT SURVIVAL INDUCED BY COMBINED ADMINISTRATION OF DONOR-SPECIFIC SPLENOCYTE TRANSFUSION(DSST) AND CTLA4Ig.
COSTIMULATION PATHWAYS OPERATIVE IN HOST IMMUNE RESPONSES TO ALLOGENEIC HEPATOCYTES.
LOCAL VS. SYSTEMIC IMMUNE INHIBITION FOLLOWING TRANSDUCTION OF LIVER ALLOGRAFTS WITH CTLA4IG
DIFFERENTIAL EFFECTS OF CD4 AND CD8 CELLS ON APOPTOSIS IN SMALL INTESTINAL TRANSPLANTATION
ACCELERATED RATE OF ACUTE REJECTION OF RENAL ALLOGRAFTS FROM BRAIN DEAD DONORS.
INHIBITION OF HUMAN SKIN ALLOGRAFT REJECTION BY BLOCKADE OF CD28-B7 AND CD40-CD154 COSTIMULATION IN THE HUMANIZED SCID MOUSE (HuSCID).
INTERLEUKIN-1ß CONVERTING ENZYME (ICE) MEDIATES RENAL ISCHEMIC-REPERFUSION INJURY IN MICE.
THE IMPACT OF TRANSIENT ANTI-DONOR ANTIBODIES IN A RAT LUNG TRANSPLANT MODEL
DISTINCT SENSITIZATION PATHWAYS IN LIVER TRANSPLANT RECIPIENTS
CMV Antigenemia Directed Preemptive Prophylaxis with Oral Ganciclovir for the Prevention of CMV Disease in Liver Transplant Recipients: A Prospective, Randomized, Controlled Trial.
EFFECT OF ORAL ACYCLOVIR OR GANCYCLOVIR AFTER PREEMPTIVE INTRAVENOUS GANCYCLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE THERAPY.
NOVEL MECHANISM OF CYTOMEGALOVIRUS INHIBITION BY LEFLUNOMIDE: EQUIVALENT ACTIVITY AGAINST GANCICLOVIR/FOSCARNET-SENSITIVE AND RESISTANT ISOLATES.
COMPARISON OF PRE-EMPTIVE THERAPY BASED ON PCR WITH PROPHYLAXIS FOR PREVENTION OF CMV DISEASE OCCURRENCE IN HIGH RISK TRANSPLANT PATIENTS
PREVENTION OF CYTOMEGALOVIRUS INFECTION POST-RENAL TRANSPLANTATION(Clinical practice guidelines):
INTRAOPERATIVE HYPOTHERMIA IS AN INDEPENDENT RISK FACTOR FOR CYTOMEGALOVIRUS (CMV) INFECTION IN LIVER TRANSPLANT RECIPIENTS.
CMV viral load in renal allograft recipients
INCIDENCE OF GASTROINTESTINAL CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS WITH ABDOMINAL PAIN ON MYCOPHENOLATE MOFETIL
THE RISK OF TRANSFUSION-ACQUIRED CYTOMEGALOVIRUS (CMV) INFECTION IN SERONEGATIVE SOLID ORGAN TRANSPLANT RECIPIENTS RECEIVING UNSCREENED BLOOD PRODUCTS (1984-1996).
PRESENCE OF CELL MICROCHIMERISM IN PERIPHERAL BLOOD OF HIGHLY SENSITIZED PATIENTS WAITING FOR RENAL TRANSPLANTATION: POSSIBLE MECHANISM FOR LONG TERM MAINTENANCE OF ANTIBODY TITERS?
CAN AN IMMUNE, NON-REACTIVE (ANTI-HLA) RECIPIENT BE TRANSPLANTED WITHOUT A DONOR-SPECIFIC CROSSMATCH?
EFFICACY AND CLINICAL RELEVANCE OF ELISA-BASED CROSSMATCHING (XM) RELATIVE TO THE COMPLEMENT-DEPENDENT CYTOTOXICITY (CDC) XM
RE-EVALUATION OF THE CORRELATION BETWEEN PRA-STAT® REACTIVITY AND RENAL ALLOGRAFT OUTCOME IN LIGHT OF EXTENSIVE REDEFINITION OF THE HLA ANTIGEN PANEL
POST-TRANSPLANT FLOW CYTOMETRY CROSSMATCH AND ACUTE REJECTION IN RENAL TRANSPLANTATION
LONG-TERM IMPROVEMENT OF GRAFT SURVIVAL IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING
IMPACT OF RACE, TRANSFUSIONS AND PREGNANCY ON RENAL ALLOGRAFT OUTCOME IN FEMALE RECIPIENTS
ALLOSPECIFIC IFN-γ-PRODUCING CELLS IN PERIPHERAL BLOOD AS A FUNCTIONAL MEASURE OF HLA HAPLOTYPE MATCH.
METALLOPROTEINASE GENERATES SOLUBLE MHC CLASS I BY CELL SURFACE CLEAVAGE
CLONING OF THE PORCINE COSTIMULATORY MOLECULE CD40.
PROTECTIVE GENES IN XENOGRAFTS CAN BE INDUCED WITHOUT T CELLS OR XENOREACTIVE ANTIBODIES.
RODENT TESTIS IS NOT AN IMMUNE PRIVILEGED TRANSPLANTABLE TISSUE
Adhesion Molecules Regulating Human Leukocyte Attachment to Porcine Vascular Endothelium
XENOGENEIC THYMIC TRANSPLANTATION IN A PIG-TO-NON-HUMAN-PRIMATE MODEL
HAMSTER BLOOD TRANSFUSION CAN INDUCE TOLERANCE TO CARDIAC XENOGRAFTS IN ABSENCE OF T-CELLS
SYNERGISTIC ACTIVITY OF MALONONITRILAMIDES (MNAs) WITH TACROLIMUS (FK 506) TO INDUCE LONG-TERM SKIN XENOGRAFT SURVIVAL.
SUSTAINED DECREASE OF SERUM ANTI-GAL IgG ANTIBODIES IN BABOONS BY REMOVING AEROBIC GRAM NEGATIVE BACTERIA FROM THE BOWEL AND WITH CYCLOPHOSPHAMIDE TREATMENT.
CHARACTERISTICS OF B LYMPHOCYTE AND NK CELL TOLERANCE IN A HAMSTER-TO-ATHYMIC NUDE RAT CARDIAC XENOTRANSPLANTATION MODEL
PORCINE ENDOGENOUS RETROVIRUSES AND THE SAFETY OF XENOTRANSPLANTATION
ANALYSIS OF PUBLIC AND PRIVATE T CELL REPERTOIRE (TCR) IN A CONCORDANT HAMSTER TO RAT CARDIAC XENOGRAFT MODEL.
IN-VIVO IN-VITRO.CORRELATES OF XENOGRAFT TOLERANCE IN LONG-SURVIVING FUNCTIONAL TOLERANCE (LSFT) OF CARDIAC XENOGRAFTS (CX)
OPERATIONAL TOLERANCE (OT) OF LONG-SURVIVING CARDIAC XENOGRAFTS (LSCX) IS RELATED TO MODIFICATION OF THE GRAFT-IN-RESIDENCE AND NOT TO INDUCED TOLERANCE IN THE RECIPIENT: STUDIES OF RETRANSPLANTED LSCX
CYTOKINE PRODUCTION FROM NON-PARENCHYMAL CELLS IN ISOLATED XENOPERFUSED RATLIVER.
INDUCTION OF SPECIES-SPECIFIC HOST ACCOMMODATION IN THE HAMSTER-TO-LEWIS RAT TRANSPLANTATION MODEL
COLLAGENASE DIGESTION OF THE PIG PANCREAS MODIFIES THE EXPRESSION OF GALα1-3GAL, Pk AND THOMSEN-FRIEDENREICH ANTIGENS ON ADULT PORCINE ISLETS
A New Model for the Study of Vascular Hyperacute Rejection in Xenotransplantation.
CHARACTERIZATION OF XENOGRAFT RESISTANCE TO AUTOIMMUNE DISEASE RECURRANCE(ADR) AFTER PANCREAS ISLET (PI) TRANSPLANTS
CERTAIN SUBTYPES OF COMPLEMENT-FIXING XENOREACTIVE ANTIBODIES ARE A MAJOR FACTOR IN XENOGRAFT REJECTION.
INVESTIGATION OF HEMOLYSIS ASSOCIATED WITH LONG-TERM PERFUSION OF hDAF AND NORMAL PORCINE LIVERS WITH HUMAN BLOOD.
ANTI-FORSSMAN ANTIBODIES IN THE RAT-ANTI-MOUSE SERA ARE NOTRESPONSIBLE FOR REJECTION OF MOUSE CARDIAC XENOGRAFTS IN RATS
A NEW SMALL ANIMAL MODEL DEMONSTRATES THAT T-LYMPHOCYTES ARE ESSENTIAL FOR REJECTION OF VASCULARIZED CARDIAC CONCORDANT XENOGRAFTS
HUMAN ANTI PORCINE XENOGENEIC T CELL RESPONSE IN VITRO : STUDY OF MIXED LEUCOCYTE REACTIONS AND MIXED LYMPHOENDOTHELIAL CULTURES
TACROLIMUS PREVENTS ISLET XENOGRAFT REJECTION: A STUDY IN THE PIG-TO-RAT MODEL
Rapid Destruction of Porcine Islets of Langerhans by Fresh Human Blood.
THE ROLE OF EARLY IMMUNE ACTIVATION AND LEUCOCYTE APOPTOSIS IN INDUCTION OF SPONTANEOUS LIVER TRANSPLANT TOLERANCE.
Transferable Allograft Tolerance Induced by Anti-LFA-1 (CD11a) Therapy
NONRESPONSIVENESS TO CARDIAC ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF CLASS I ALLOPEPTIDES IS ASSOCIATED WITH LOCAL AND SYSTEMIC EXPRESSION OF TH2 CYTOKINES
CELLS FROM TOTAL LYMPHOID IRRADIATED MICE INHIBIT DIFFERENTIATION OF ANTIGEN SPECIFIC TH1 CD4+ CELLS
Characterization of Novel Surface Molecules on the Facilitating Cell.
NEONATAL TOLERANCE IS DEPENDENT UPON THYMIC MECHANISMS
ALLOGENEIC LIVER-DERIVED DENDRITIC CELL PROGENITORS FAIL TO STIMULATE INTRACELLULAR TH1 CYTOKINE PRODUCTION AND INDUCE ONLY LOW LEVELS OF ANTI-DONOR CTL: ASSOCIATION WITH `SPONTANEOUS' LIVER ALLOGRAFT ACCEPTANCE.
TRANSIENT ENRICHMENT OF IL-4 PRODUCING CD4-T NK CELLS DURING THE INDUCTION PHASE OF TOLERANCE FOLLOWING TOTAL LYMPHOID IRRADIATION
BOTH HEPATOCYTES AND LIVER NON-PARENCHYMAL CELLS ARE INDUCERS OF APOPTOSIS IN ACTIVATED T CELLS
COMBINED SIMULTANEOUS BLOCKADE OF CD28/B7 AND CD40/CD40L COSTIMULATORY PATHWAYS RESULTS IN LONG-TERM ACCEPTANCE OF PANCREATIC ISLET ALLOGRAFTS
IMMUNE MODULATION IN ORGAN RECIPIENTS BY SINGLE OR MULTIPLE DONOR BONE MARROW INFUSIONS
A PARTIAL CONDITIONING MODEL TO ACHIEVE HEMATOPOIETIC STEM CELL (HSC) CHIMERISM IN MICE WITH TYPE 1 DIABETES
TGFβ REGULATES CELL-MEDIATED IMMUNITY IN LONG-TERM ALLOGRAFT RECIPIENTS
TOLERANCE INDUCTION IN RATS DOES NOT REQUIRE GRAFT RESIDENT DONOR-TYPE ANTIGEN PRESENTING CELLS
INDUCTION OF DONOR SPECIFIC ACQUIRED THYMIC TOLERANCE BY INTRATHYMIC INOCULATION OF A SINGLE SYNTHETIC ALLO-MHC CLASS I PEPTIDE [RT1.Au],
Intrathymic Administration of B Cells Induces Prolonged Survival of Fully Allogeneic Cardiac Grafts by Non-deletional Mechanisms
A ROLE OF CD8+ T-CELLS IN THE INDUCTION OF ALLOGRAFT TOLERANCE BY DONOR-SPECIFIC BLOOD TRANSFUSION.
THE INDUCTION OF REGULATORY T CELLS IN THE INFECTIOUS TOLERANCE PATHWAY IN ALLOGRAFT RECIPIENTS IS THYMUS DEPENDENT
DONOR SPECIFIC HYPO-RESPONSIVENESS MAY NOT BE STABLE IN HUMAN LIVER ALLOGRAFT RECIPIENTS PREDICTED TOLERANT BY IN VITRO T-CELL FUNCTION ASSAYS.
ADULT VASCULARIZED THYMUS TRANSPLANTATION RESTORES HOST IMMUNOCOMPETENCE
Immune Priviledge of Liver Allografts is Regulated by Fas-L (CD95L)
DISTINCT TOLERANCE PATHWAYS IN SENSITIZED GRAFT RECIPIENTS
FAILURE OF FIBRONECTIN EXPRESSION BY GRAFT INFILTRATING MACROPHAGES IS ASSOCIATED WITH THE INFECTIOUS TOLERANCE PATHWAY IN CD4 MAB-TREATED RAT RECIPIENTS
AN ACTIVE REGULATORY MECHANISM OF ALLOGRAFT TOLERANCE INDUCED BY CD45RB MONOCLONAL ANTIBODY (mAb)
SYNERGY OF CLASS I AND CLASS II MHC DEFICIENCY(1D AND C2D) ISLETS AND EARLY SHORT TERM SUPPRESSION IN ACHIEVING LONG TERM ISLET GRAFT (IG) SURVIVAL AND TOLERANCE INDUCTION
INVOLVEMENT OF CD26/DPP IV IN ALLOANTIGEN-INDUCED HUMORAL IMMUNE RESPONSES IN ALLOGRAFT RECIPIENTS
DIVERGENT EFFECTS OF CONVENTIONAL IMMUNOSUPPRESSION AGENTS ON GENE THERAPY IN TRANSPLANTATION
PROLONGATION OF MURINE CARDIAC AND SKIN ALLOGRAFT SURVIVAL BY ANTI-CD40 MONOCLONAL ANTIBODY
COMBINED USE OF TACROLIMUS (FK506) AND LEFLUNOMIDE (LEF) RESULTS IN PROLONGATION OF PANCREATIC ISLET ALLOGRAFT SURVIVAL
PRAVASTATIN-INDUCED SURVIVAL IN RAT ORTHOTOPIC LIVER TRANSPLANTATION IS ACCOMPANIED BY DIMINISHED EXPRESSION OF β2-GLYCOPROTEIN-I AND PROINFLAMMATORY CYTOKINES
EFFECT OF ANTI-LFA-1 MONOCLONAL ANTIBODY ON POST-ISCHEMIC INJURY IN ISOLATED KIDNEY REPERFUSION
NONDEPLETING ANTI-CD4 ANTIBODY PROLONGS ADENOVIRUS-MEDIATED TRANSGENE EXPRESSION IN SYNGENEIC HEART TRANSPLANTS.
IMMUNOMODULATORY FUNCTION OF LOW MOLECULAR WEIGHT HYALURONATE DELAYS ALLOGRAFT REJECTION AND IMPROVES SURVIVAL IN A RAT ACUTE KIDNEY REJECTION MODEL.
Coadministration of neoral and the novel rapamycin analog, sdzrad,to. lung allograft recipients:potentiation of immunosuppressive efficacy and reduction of toxicity by staggered vs. simultaneous treatment
ALLOTRAP PEPTIDE MEDIATED HEME OXYGENASE - I MODULATION AND IMMUNOSUPPRESSION
EFFECT OF TACROLIMUS (FK506) AND SIROLIMUS (RAPA) MONO- AND COMBINATION-THERAPY IN PROLONGATION OF RENAL GRAFT SURVIVAL IN THE MONKEY
Low-dose oral sirolimus prolongs survival after orthotopic liver transplantation in a porcine model.
COADMINISTRATION OF MICROEMULSION CYCLOSPORINE AND THE NOVEL LEFLUNOMIDE MALONONITRILAMIDE ANALOG, HR1279, MORE EFFECTIVELY SUPPRESSES RAT LUNG ALLOGRAFT REJECTION THAN MICROEMULSION CYCLOSPORINE PLUS LEFLUNOMIDE
GELDANAMYCIN DISRUPTS THE P56LCK-HEAT SHOCK PROTEIN-90 COMPLEX IN T-CELLS.
PROLONGED SURVIVAL OF RAT LIVER ALLOGRAFTS TRANSFECTED WITH FAS-LIGAND EXPRESSING PLASMID
Tamoxifen Prolongs Heart Allograft Survival In Cyclosporin Treated Female Mice
FLOW CYTOMETRIC (FCM) ANALYSIS OF THE MOLECULAR MECHANISMS OF IMMUNOSUPPRESSIVE ACTION OF THE ACTIVE METABOLITE OF LEFLUNOMIDE AND ITS MALONONITRILAMIDE (MNA) ANALOGS IN A NOVEL WHOLE BLOOD ASSAY
INHIBITION OF NITRIC OXIDE SYNTHASE ISOFORMS BY IMMUNOSUPPRESSIVE PEPTIDES
ALTERATIONS IN T CELL EFFECTOR MECHANISMS FOLLOWING TRANSFERRIN RECEPTOR BLOCKADE
TGF-β MIMICS AND ANTI-TGF-β REVERSES THE ANTI-PROLIFERATIVE EFFECTS OF CYCLOSPORINE IN VIVO
TEMPORAL RELATION OF IMMUNOREGULATORY (SUPPRESSOR) CELL FUNCTION AND SKIN GRAFT SURVIVAL IN MICE TREATED WITH SIROLIMUS (SIR), ANTILYMPHOCYTE SERUM(ALS) AND DONOR SPECIFIC BONE MARROW (BM).
PRELIMINARY EXPERIENCE WITH TROGLITAZONE (REZULIN) IN KIDNEY AND KIDNEY/PANCREAS TRANSPLANT RECIPIENTS
TACROLIMUS USE IN KIDNEY-PANCREAS RECIPIENTS IS ASSOCIATED WITH LESS ACUTE RENAL DYSFUNCTION THAN CYCLOSPORINE
OUTPATIENT RENAL TRANSPLANT BIOPSIES WITH A THREE HOUR OBSERVATION PERIOD: A SINGLE CENTER EXPERIENCE.
LONG-TERM OUTCOME IN SIMULTANEOUS KIDNEY AND PANCREAS (SKP) TRANSPLANT RECIPIENTS WITH FUNCTIONING ALLOGRAFTS AT ONE YEAR AFTER TRANSPLANTATION
EFFECTS OF PROPHILACTIC ANTITHYMOCYTIC GLOBULINS (ATG) ON KIDNEY REJECTION RATE IN PATIENTS UNDERGOING KIDNEY-PANCREAS TRANSPLANTATION:
CHRONIC REJECTION IN PANCREAS TRANSPLANTATION: RISK FACTORS AND THE CONTRIBUTION TO GRAFT LOSS
CORRELATION OF HISTOLOGIC GRADES OF PANCREAS ALLOGRAFT REJECTION TO SERUM ENZYMES AND BLOOD GLUCOSE.
CHRONIC PANCREAS ALLOGRAFT REJECTION: MORPHOLOGICAL FINDINGS AND CLINICAL CORRELATION
INCIDENCE AND MANAGEMENT OF MYCOPHENOLATE MOFETIL ADVERSE EFFECTS IN SIMULTANEOUS KIDNEY/PANCREAS TRANSPLANT RECIPIENTS
EFFICACY OF ORAL GANCICLOVIR VS. ORAL ACYCLOVIR FOR CMV PROPHYLAXIS IN KIDNEY/PANCREAS AND PANCREAS ALONE RECIPIENTS
OKT3 AS PRIMARY THERAPY FOR BIOPSY PROVEN ACUTE RENAL ALLOGRAFT REJECTION IN SIMULTANEOUS KIDNEY AND PANCREAS TRANSPLANT (SKP) RECIPIENTS
EVALUATION OF THE ARTERIAL FLOW OF THE PANCREATIC GRAFT WITH DUPLEX-DOPPLER ULTRASONOGRAPHY
EXPERIENCE WITH AZATHIOPRINE WITHDRAWAL AFTER SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION
Differences in Recurrent Genetic Anomalies in EBV-associated Pediatric Cancer: Use of Microdissected Archival Material
TREATMENT OF SUBCLINICAL ACUTEREJECTION (SAR) IMPROVES LONG-TERM GRAFT SURVIVAL BY PREVENTING LATE ACUTE REJECTION IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
EFFECT OF MYCOPHENOLATE MOFETIL (MMF) ON CD4+/CD8+, RATIO IN PEDIATRIC RENAL TRANSPLANTATION (Tx).
FIVE YEARS POST TRANSPLANT STATUS IN 96 CHILDREN WHO RECEIVED OLT BETWEEN 1984 AND 1990.
SURVIVAL AFTER ACUTE GRAFT FAILURE IN PEDIATRIC THORACIC ORGAN TRANSPLANT RECIPIENTS.
HYPERBARIC OXYGEN THERAPY FOR HEPATIC ARTERY THROMBOSIS FOLLOWING PEDIATRIC LIVER TRANSPLANTATION
KIDNEY TRANSPLANTATION IN CHILDREN UNDER 5 YEARS OF AGE
REJECTION INCIDENCES AFTER PEDIATRIC LIVER TRANSPLANTATION WITH CADAVERIC OR LIVING-RELATED DONORS: AN IMMUNOLOGICAL PARADOX?
Use of Mycophenolate in Pediatric Liver Transplantation.
PREVALENCE AND RISK FACTORS FOR ANEMIA IN PEDIATRIC RENAL TRANSPLANT (RTx) RECIPIENTS
STRUCTURE AND FUNCTION OF HIGH RISK DONOR KIDNEYS CORRELATE WITH RECIPIENT GRAFT OUTCOME
LONG-TERM GRAFT SURVIVAL IN LIVING KIDNEY TRANSPLANTATION FROM ELDERLY DONORS.
Renal Transplantation in Patients with Prior Thoracic Organ Transplants
RACIAL DIFFERENCES IN LIVING DONOR KIDNEY TRANSPLANTATION
PRIMARY LIVING UNRELATED DONOR KIDNEY TRANSPLANTATIONS IN THE CYCLOSPORINE ERA.
LIVING-UNRELATED RENAL DONOR TRANSPLANTS: DONOR AND RECIPIENT ATTITUDES
Clinical Monitoring of Cyclosporine:Capillary Whole Blood Collected With the Cyclostat™ collection Device.
Conversion From Cyclosporine To Azathioprine At One Year After HLA-Identical Living Related Renal Transplantation: 12 Year Follow Up.
POSITIVE REMOTE CROSSMATCH IS ASSOCIATED WITH REDUCED GRAFT SURVIVAL IN CADAVERIC RENAL TRANSPLANTATION
SHARED DONOR-HUSBAND HLA MISMATCH AS A PROGNOSTIC FACTOR FOR RENAL GRAFT REJECTION IN PATIENTS WITH PREVIOUS PREGNANCIES
PRE-TRANSPLANT SYSTEMIC INFLAMMATION PREDICTS ACUTE REJECTION AFTER RENAL TRANSPLANTATION
Microalbuminuria Following Renal Transplantation
LOW-DOSE ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACEi) ARE SAFE AND EFFECTIVE IN REDUCING PROTEINURIA (UPROT) IN RENAL ALLOGRAFT RECIPIENTS.
IMPROVING COLOR DOPPLER EVALUATION OF KIDNEY TRANSPLANTATION WITH A NEW ULTRASOUND CONTRAST MEDIUM
LONG-TERM OUTCOMES IN DIABETICS FOLLOWING CADAVERIC RENAL TRANSPLANTATION
Survival of Patients with Preexisting Coronary Artery Disease (CAD) Following Kidney or Kidney/Pancreas Transplantation with
Pre and post-grafting immunological and clinical factors influencing the survival of a second kidney transplant. An one center study.
RISK FACTORS FOR GRAFT LOSS AFTER INITIALLY SUCCESSFUL RENAL TRANSPLANTATION.
SIMULTANEOUS DOUBLE KIDNEY TRANSPLANT FROM VERY OLD DONORS.
IS ALLOGRAFT AND PATIENT OUTCOME AFFECTED BY PRETRANSPLANT DISEASE?
COMPARISON OF PATIENTS WITH AND WITHOUT STATUS CHANGES AFTER RE-EVALUATION FOR RENAL TRANSPLANT
THE TRANSPLANT OF IMMUNIZED PATIENTS: FOUR YEARS OF EXPERIENCE IN A SINGLE CENTRE USING AN ELISA METHOD DETECTING ANTI HLA SPECIFICITY.
KIDNEY TRANSPLANTATION FOR END STAGE RENAL FAILURE IN LIVER TRANSPLANT RECIPIENTS CARRIERS OF HEPATITIS C VIRUS.
HIGH MORTALITY IN THE FIRST YEAR AFTER GRAFT LOSS IN ELDERLY KIDNEY RECIPIENTS
MODIFIED EXTRAVESICAL URETERONEOCYSTOSTOMY AND ROUTINE STENTING IN RENAL TRANSPLANTATION: EXPERIENCE IN 250 CONSECUTIVE CASES.
DONOR HCV STATUS DOES NOT ADVERSELY AFFECT OUTCOMES IN HCV+RECIPIENTS IN RENAL TRANSPLANTATION
POST RENAL TRANSPLANT MALIGNANCIES: A CHANGING PATTERN IN A SINGLE CENTRE
SAFETY AND EFFICACY OF ATORVASTATIN IN RENAL TRANSPLANT RECIPIENTS
HYPERHOMOCYSTEINEMIA AND OTHER CORONARY RISK FACTORS IN 20-YEAR RENAL TRANSPLANT RECIPIENTS (Level 5A) WITH AND WITHOUT CORONARY HEART DISEASE (CHD)
RED BLOOD CELL MASS (RBCM) AND PLASMA VOLUME (PV) IN RENAL TRANSPLANT PATIENTS (RTP) WITH ERYTHROCYTOSIS (ERY): THE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACEI).
COLONIC ULCERATION - A PREVIOUSLY UNREPORTED ADVERSE EFFECT OF MYCOPHENOLATE MOFETIL.
Prevaience and clinical significance of antiphospholipid antibodies in renal transplant recipients.
RECURRENT/DE NOVO MEMBRANOUS NEPHROPATHY AFTER RENAL TRANSPLANTATION: A REPORT FROM THE RENAL ALLOGRAFT DISEASE REGISTRY(RADR)
ARTERIAL VESSEL WALL HYPERTROPHY IN RENAL TRANSPLANT RECIPIENTS: EFFECTS OF ACE INHIBITOR AND ß-BLOCKER TREATMENT.
WHAT IS THE ROLE OF HHV 8 IN ETIOPATHOGENESIS OF KAPOSI'S SARCOMA OCCURRED AFTER KIDNEY TRANSPLANTATION?
RECURRENT LUPUS NEPHRITIS AFTER RENAL TRANSPLANTATION: MORE FREQUENT THAN WE THOUGHT.
Post-renal Transplantation Diabetes Mellitus - A Retrospective Study
INCIDENCE OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN KIDNEY ALLOGRAFT PATIENTS
RESPONSE OF WASHED PLATELETS FROM CYCLOSPORINE-A AND FK506- TREATED RENAL TRANSPLANT RECIPIENTS TO STIMULATORY AGONISTS DOES NOT DIFFER FROM CONTROLS
HYPERGLYCEMIA AFTER RENAL TRANSPLANTATION
INCREASED LEVELS OF ALPHA-2,6-SIALYLTRANSFERASE PRE-TRANSPLANT PREDICT DELAYED GRAFT FUNCTION IN KIDNEY TRANSPLANTS.
DURATION OF DELAYED GRAFT FUNCTION PREDICTS LONG TERM GRAFT SURVIVAL. NEED FOR DIALYSIS IS NOT AN OPTIMAL CRITERIUM
A COMPARATIVE STUDY OF 500 MG BID AND 250 MG BID OF PROPHYLACTIC ORAL GANCILOVIR IN POST-KIDNEY TRANSPLANT “CMV AT RISK” RECIPIENTS.
THE IMPACT OF MYCOPHENOLATE MOFETIL (MMF) ON CYTOMEGALOVIRUS (CMV) DISEASE.
QUANTITATION OF CMV VIRAL INFECTION IN ADULT RENAL TRANSPLANT RECIPIENTS UTILIZING QUANTITATIVE PCR AND THE CMV ANTIGENEMIA TEST.
PROPHYLAXIS OF VIRAL AND FUNGAL INFECTIONS AFTER SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION
CLINICAL COURSE OF CYTOMEGALOVIRUS (CMV) VIREMIA WITH AND WITHOUT GANCICLOVIR TREATMENT IN CMV-SEROPOSITIVE RENAL TRANSPLANT RECIPIENTS: LONGITUDINAL STUDY OF CMV PP65 ANTIGENEMIA ASSAY
POST KIDNEY TRANSPLANT CMV INCIDENCE IN THE GANCYCLOVIR ERA: MONITORING VIRAL DNA BY A CMV PCR ASSAY
TRANSPLANTATION SUPPRESSES LEUKOCYTOSIS BUT NOT FEVER IN PATIENTS WITH BACTERIAL OR FUNGAL INFECTION
IS AZATHIOPRINE HARMFUL TO CHRONIC VIRAL HEPATITIS IN RENAL TRANSPLANTATION? A LONG-TERM FOLLOW-UP STUDY ON AZATHIOPRINE WITHDRAWAL
EFFICACY AND TOLERANCE OF ALPHA INTERFERON TREATMENT IN DIALYSIS PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV): RESULTS OF A PROSPECTIVE PILOT STUDY
GANCICLOVIR PROPHYLAXIS IS MORE EFFECTIVE THAN INTRAVENOUS IMMUNOGLOBULIN(IVIG) IN PREVENTING CYTOMEGALOVIRUS (CMV) DISEASE IN RENAL TRANSPLANT RECIPIENTS
CLOSTRIDIUM DIFFICILE COLITIS AFTER RENAL TRANSPLANTATION
HELICOBACTER PYLORI - IS IT IMPORTANT IN THE MULTI-ORGAN TRANSPLANT POPULATION?
ACUTE RENAL ALLOGRAFT DYSFUNCTION AND POLYOMA VIRUS INFECTION: ACUTE TUBULAR NECROSIS-LIKE CHANGES IN ABSENCE OF ACUTE REJECTION
PROCALCITONIN (PCT) A NEW MARKER FOR DIFFERENTIAL DIAGNOSIS OF ACUTE REJECTION (AR) AND BACTERIAL INFECTION (BI) HEART TRANSPLANTATION.
Development of an Immunosuppressed, Catheterized Murine Model for Ascending Candida albicans Urinary Tract Infection
Chagas' disease in kidney transplant patients
FK506 IS A SAFE AND EFFECTIVE TREATMENT FOR MODERATE REJECTION IN HEART TRANSPLANT RECIPIENTS.
CHANGES IN HOMOCYSTEINE CONCENTRATION AFTER ORTHOTOPIC HEART TRANSPLANTATION
Detection of Biopsy Negative Hemodynamically Significant Heart Transplant Rejection by Doppler Tissue Imaging
ARE BIOCHEMICAL INDICES OF ACUTE CARDIAC INJURY USEFUL IN PREDICTING CARDIAC ALLOGRAFT REJECTION?
Quilty B Lesions on Endomyocardial Biopsies: Are They Associated with Subsequent Histologic Rejection in Cardiac Transplant Patients?
Delayed Acute Allograft Rejection Occurring in Patients who Survive the First Year Post Heart Transplant.
SHORT TERM USE OF INDUCTION OKT3 IN URGENT HEART TRANSPLANTATION: IMPACT ON LONG TERM CLINICAL OUTCOMES
Long Term Follow-up of Heart Transplant Recipients Treated for Acute Allograft Rejection with Methotrexate and/or OKT3.
OUTPATIENT OKT3 FOR CARDIAC ALLOGRAFT REJECTION - IS IT SAFE AND COST EFFECTIVE?
THE TNF-α SYSTEM BEFORE AND AFTER HEART TRANSPLANTATION: PLASMA PROTEIN LEVELS, mRNA-EXPRESSION, SOLUBLE RECEPTORS AND SERUM BUFFER CAPACITY
Detection of Coronary Calcification by Electron Beam Computed Tomography in Cardiac Transplant Recipients
SAFETY AND TOLERABILITY OF TWO DIFFERENT SINGLE DOSES OF SDZ RAD IN LUNG TRANSPLANT RECIPIENTS.
NEORAL DOSE MONITORING WITH 2 HOUR POST-DOSE LEVELS IN HEART TRANSPLANT PATIENTS RECEIVING ANTITHYMOCYTE GLOBULIN INDUCTION: A PILOT STUDY.
COMPARISON OF MICROEMULSION FORMULATION WITH OIL BASED CYCLOSPORINE IN CARDIAC TRANSPLANT PATIENTS
INTENSIVE CARE UNIT OUTCOMES OF LUNG RECIPIENTS BEYOND THE PERITRANSPLANT PERIOD
A RANDOMIZED CONTROLLED COMPARISON OF THE EFFICACY AND SAFETY OF PRAVASTATIN AND SIMVASTATIN IN HEART TRANSPLANTATION
A SAFE STRATEGY FOR POSTOPERATIVE TREATMENT IN HEART TRANSPLANT RECIPIENTS BETWEEN 60 - 70 YEARS OF AGE
At What Creatinine Level is Angiographic Dye safe for Coronary Angiography in Cardiac Transplant Recipients?
ASSOCIATION BETWEEN PERIOPERATIVE RENAL FUNCTION AND TIME TO CHRONIC RENAL INSUFFICIENCY FOLLOWING ORTHOTOPIC HEART TRANSPLANTATION
The Effect of Ischemic Time On Rejection and Survival in Cardiac Transplant Recipients.
TREATMENT OF ATRIAL FLUTTER IN CARDIAC TRANSPLANT RECIPIENTS
Four Year Series of Patients with LVAD-Related Infections: Clinical and Microbiologic Experience with Cardiac Transplantation
Cardiowest Total Artificial Heart as Successful Bridge to Heart Transplantation in Terminally Ill Heart Failure Patients.
One Year Follow-up of Patients Bridged to Heart Transplantation with Jarvik 7 and Cardiowest Total Artificial Heart.
EX-VIVO GENERATION OF FACILITATING CELLS.
MODULATION OF HEME OXYGENASE (HSP-32) BY COBALT-PROTOPORPHYRIN ABROGATES DEVELOPMENT OF ACUTE GVHD IN A PARENT TO F1 MOUSE MODEL
CD8+ CELLS IN THE PERIPHERAL BLOOD OF MICE TREATED WITH G-CSF ENHANCE THE ENGRAFTMENT OF PURIFIED HEMATOPOIETIC STEM CELLS ACROSS ALLOGENEIC BARRIERS.
Mixed multilineage chimerism in CD8-Knockout mice following allogeneic bone marrow transplantation with partial conditioning.
INFLUENCE OF ADDITIONAL ADMINISTRATION OF HOST-TYPE BONE MARROW ON THE IMMUNE TOLERANCE OF MIXED ALLOGENEIC CHIMERAS
IMPAIRED ACTIVATION-INDUCED T CELL APOPTOSIS AND FAILURE TO INDUCE LONGTERM ALLOGRAFT SURVIVAL IN INTERLEUKIN-2 (IL-2)-DEFICIENT MICE.
HIGHER PRETRANSPLANT HCV RNA LEVELS ASSOCIATED WITH POOR PATIENT AND GRAFT SURVIVAL
Th1 responses control development of graft vasculopathy: Insights from studies in STAT4-knock out mice
A STUDY COMPARING MYCOPHENOLATE MOFETIL (MMF) TO AZATHIOPRINE (AZA) IN SIMULTANEOUS PANCREAS-KIDNEY (SPK) TRANSPLANTATION
ACTIVATION OF CD40 ON HUMAN HEPATOCYTES INCREASES FAS LIGAND EXPRESSION AND INDUCES APOPTOSIS: A NOVEL MECHANISM OF HEPATOCYTE LOSS IN LIVER ALLOGRAFT REJECTION:
RECURRENT AND DE NOVO DISEASES AFTER RENAL TRANSPLANTATION: A REPORT FROM THE RENAL ALLOGRAFT DISEASE REGISTRY (RADR)
ARE PROFESSIONAL ANTIGEN PRESENTING CELLS (APCs) NECESSARY TO INITIATE GRAFT REJECTION?
INDIRECT ALLORECOGNITION OF DONOR CLASS II MHC PEPTIDES INDUCES ANTIBODY MEDIATED VASCULAR REJECTION OF CARDIAC ALLOGRAFTS
EFFECT OF HLA-DR AND CLASS I CREG MATCHING CARDIAC TRANSPLANTS(TNX): AN ANALYSIS OF ACCESS AND OUTCOME
THE COST-EFFECTIVENESS OF TRANSPLANTATION WITH EXPANDED DONOR KIDNEYS(EDKs)- A MARKOV MODEL
PROLONGED HYPERTENSION (>10 YEARS) IS A SIGNIFICANT RISK FACTOR IN OLDER CADAVER DONOR RENAL TRANSPLANTS.
Immunoglobulins are directly involved in the pathogenesis of idiopathic nephrotic syndrome recurrence after renal transplantation.
ODDS PROBABILITY OF COMPLIANCE AND NON-COMPLIANCE IN PATIENTS WITH A FUNCTIONING RENAL TRANSPLANT- A MULTI CENTER STUDY
FK506 MODIFIES RISK FACTORS FOR CHRONIC ALLOGRAFT INJURY IN AFRICAN-AMERICAN RENAL ALLOGRAFT RECIPIENTS
THE COURSE AND MANAGEMENT OF HEPATITIS B AND C IN TWENTY-YEAR RENAL ALLOGRAFT RECIPIENTS (LEVEL 5A)
RENAL TRANSPLANTATION FOR ESRD FOLLOWING BONE MARROW TRANSPLANTATION: A REPORT OF 5 CASES, WITH AND WITHOUT IMMUNOSUPPRESSION.
ONE-YEAR OUTCOME AFTER STEROID WITHDRAWAL FROM A SIROLIMUS-CYCLOSPORINE-PREDNISONE REGIMEN IN CADAVER- AND LIVING-DONOR RECIPIENTS.
EARLY CORTICOSTEROID WITHDRAWAL 1 WEEK FOLLOWING RENAL TRANSPLANTATION USING TACROLIMUS (TAC)/ MYCOPHENOLATE MOFETIL (MMF) - BASED IMMUNOSUPPRESSION
TACROLIMUS AND RETRANSPLANTATION: EQUIVALENT RESULTS TO PRIMARY RENAL TRANSPLANTATION
ALOPECIA TOTALIS RELATED TO TACROLIMUS USE FOLLOWING KIDNEY AND PANCREAS TRANSPLANTATION.
RANDOMIZED COMPARATIVE TRIAL OF PROGRAF (TACROLIMUS) IN COMBINATION WITH AZATHIOPRINE OR MYCOPHENOLATE MOFETIL VS. NEORAL (CYCLOSPORINE) WITH MYCOPHENOLATE MOFETIL AFTER KIDNEY TRANSPLANTATION
Cardiovascular Risk Factors In Renal Transplant Recipients: 2-3 Year Results From The FK506 Multicenter, Randomized Comparative Trial.
THE ROLE OF CTLA4 NEGATIVE SIGNALING PATHWAY IN THE INDUCTION OF ACQUIRED THYMIC TOLERANCE IN VIVO
IL-2 DEPENDENT RAPAMYCIN RESISTENT SIGNALS ARE REQUIRED FOR TOLERANCE INDUCTION AND T CELL APOPTOSIS
ATTENUATION OF IL-2 RECEPTOR SIGNALING BY CD4-LIGATION-MOLECULAR MECHANISMS.
ALLOANTIGEN-UNRESPONSIVENESS IS ASSOCIATED WITH EARLY TCR SIGNALING DEFECTS IN VIVO
CD4 CELLS MAINTAIN CD8 T CELL ANERGY IN NEONATAL TOLERANT MICE
Anti-TCR DNA Vaccination Prolongs Heart Allograft Survival in Adult Rats.
Anti-TCR DNA Vaccination Demonstrates a Role for a CD8+ Clone in Allograft Tolerance Induction.
IL4KO MICE FAIL TO DEVELOP LONG-TERM ALLOGRAFT SURVIVAL
INFECTIOUS TOLERANCE IN RENAL ALLOGRAFTS: TH2 CYTOKINES AND INDUCTION OF “PROTECTIVE” GENES WHICH INHIBIT NF-κB ACTIVATION.
Tolerance-mediating T cells in renal allografts from anti-CD4 induced tolerant rats express IL-4 and are protected to activation-induced apoptosis(AIA) by upregulation of BAG-1 gene
INDUCTION OF THE CYCLINE INHIBITOR p21 EXPRESSION BY CYCLOSPORINE: A POSSIBLE MECHANISM FOR ITS ANTIPROLIFERATIVE EFFECTS.
EXTRACTION AND QUANTIFICATION OF CYCLOSPORINE FROM WHOLE BLOOD SAMPLES COLLECTED WITH THE CYCLOSTAT™ COLLECTION DEVICE
SYNERGISTIC EFFECTS OF MYCOPHENOLATE MOFETIL (MMF) AND SIROLIMUS(RAPAMYCIN, RAPA) IN PREVENTION OF ACUTE HEART, PANCREAS AND KIDNEY ALLOGRAFT REJECTION AND IN REVERSAL OF ONGOING HEART ALLOGRAFT REJECTION IN THE RAT
COADMINISTERED NEORAL AND THE NEW RAPAMYCIN DERIVATIVE, SDZ RAD, FOR NONHUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMCOKINETIC-BASED TRIALS TO MAXIMIZE EFFICACY AND TOLERABILITY
IN VIVO MECHANISMS OF ACTION OF LEFLUNOMIDE IN ALLO-TRANSPLANTATION AND XENO-TRANSPLANTATION.
ANTITHROMBIN III INHIBITS CON A-INDUCED PROLIFERATION OF RAT SPLEEN CELLS BY INHIBITING mRNA EXPRESSION OF T CELL GROWTH FACTORS (IL-2 and γ-IFN) AND IMPROVES PARAMETERS OF ACUTE INFLAMMATION IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT LUNG ALLOGRAFT REJECTION (AR)
RISKS AND COSTS OF DEVELOPING END-STAGE RENAL DISEASE AFTER HEART TRANSPLANTATION
LIVING UNRELATED KIDNEY DONATION: IS QUALITY OF LIFE AFFECTED?
MEDICATION COMPLIANCE FOLLOWING RENAL TRANSPLANT
WHO SHOULD BE TRANSPLANTED WITH KIDNEYS FROM IDEAL DONORS VERSUS MARGINAL DONORS?: A COST-EFFECTIVENESS ANALYSIS
ETHICAL ISSUES IN LIVING RELATED (LR) OR CADAVERIC (Cad) PEDIATRIC LIVER TRANSPLANTATION (OLT).
SIGNIFICANCE OF PATIENT, SOCIODEMOGRAPHIC, AND INSURANCE FACTORS ON ACCESS TO LIVER TRANSPLANTATION.
PREDICTORS OF LONG TERM GRAFT SURVIVAL IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS: A MULTIVARIATE ANALYSIS OF THE UNOS DATA
SINGLE CENTER EXPERIENCE OF 50 CONSECUTIVE PANCREAS TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL (MMF) AND TACROLIMUS (TAC) AS PRIMARY MAINTENANCE IMMUNOTHERAPY.
REGISTRY REPORT ON PANCREAS RETRANSPLANTATION: LOWER INCIDENCE OF REJECTION IN THE TACROLIMUS ERA.
RESPONSE TO IMMUNOSUPPRESSIVE TREATMENT FOR PANCREAS ALLOGRAFT REJECTION ACCORDING TO HISTOLOGIC GRADE
Long-term Follow-up of Mycophenolic Acid Blood Trough Levels in Graft Recipients with and without a History of Insulin-dependent Diabetes Mellitus IDDM
SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION WITHOUT ANTILYMPHOCYTE INDUCTION
ATG INDUCTION VERSUS NO ATG INDUCTION IMMUNOSUPPRESSION IN SIMULTANEOUS PANCREAS-KIDNEY (SPK) TRANSPLANTATION: RESULTS OF A SINGLE CENTER RANDOMIZED TRIAL
BENEFITS AND RISKS OF EARLY ANTI-LYMPHOCYTE RESCUE IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANT RECIPIENTS
TRENDS IN IMMUNOSUPPRESSION AFTER PANCREAS TRANSPLANTATION: EVOLUTION OR REVOLUTION?
CLINICAL FEATURES OF POLYOMA VIRUS INTERSTITIAL NEPHRITIS IN THE ALLOGRAFT KIDNEY.
CYTOTOXICITY OF LAK CELLS AND EBV-SPECIFIC T CELLS AGAINST LYMPHOBLASTOID EBV-POSITIVE B CELLS: A MODEL FOR CELLULAR THERAPY OF PTLD
Sequential Therapy of Post Transplant Lymphoproliferative Disorder (PTLD)
EBV-RELATED MONOCLONAL GAMMOPATHY (MGUS) IN LONG-TERM RENAL ALLOGRAFT RECIPIENTS IS ASSOCIATED WITH ACTIVATION OF CD8+ T CELLS WHICH MAY PREVENT DEVELOPMENT OF B-CELL LYMPHOMA
Decreased Incidence of Early Onset PTLD in Pancreas Transplant Recipients After Initiating Universal IV/Oral Ganciclovir Prophylaxis
NATURAL HISTORY OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
5, 10-MTHFR (C677T) Gene Polymorphism and Total Homocysteine Levels in Renal Transplant Recipients
POSTTRANSPLANT IMPROVEMENT IN HEART RATE VARIABILITY CORRELATES WITH IMPROVED QUALITY OF LIFE
RENAL TRANSPLANTATION IN TYPE II DIABETIC PATIENTS
RENAL FUNCTION AFTER NEPHRECTOMY IN THE ELDERLY AND HYPERTENSIVE: IMPLICATIONS FOR LIVING DONORS
IN VITRO TESTING OF FSGS PATIENT'S SERA FOR GLOMERULAR PERMEABILITY ACTIVITY (Palb)
REDUCED ACUTE REJECTION AND SUPERIOR ONE-YEAR RENAL ALLOGRAFT SURVIVAL WITH BASILIXIMAB (SIMULECT™) IN PATIENTS WITH DIABETES MELLITUS
INFLUENCE OF THE DURATION OF IL-2 RECEPTOR (IL-2R) BLOCKADE ON THE INCIDENCE OF ACUTE REJECTION EPISODES IN RENAL TRANSPLANTATION
BASILIXIMAB (SIMULECT™) REDUCES ACUTE REJECTIONS, CMV-INFECTIONS AND DURATION OF HOSPITAL STAY IN RENAL ALLOGRAFT PATIENTS
A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VS ATGAM FOR INDUCTION IN ADULT RENAL TRANSPLANT RECIPIENTS
RAPAMYCIN FOR REFRACTORY RENAL ALLOGRAFT REJECTION.
POOLED ANALYSIS OF PHASE III STUDIES OF ZENAPAX® (DACLIZUMAB), A HUMANIZED ANTI-IL-2R ANTIBODY
TARGETING THE IL-15 RECEPTOR WITH AN ANTAGONIST IL-15/Fcγ2a PROTEIN BLOCKS DTH AND ENHANCES THE ACCEPTANCE OF ISLET ALLOGRAFTS
POOLED HUMAN GAMMAGLOBULIN (IVIG) AND F(ab')2 FRAGMENTS OF IVIG INHIBIT THE MIXED LYMPHOCYTE REACTION (MLR) THROUGH DIFFERENT MECHANISMS
TRANSFECTION OF RAT HEART ALLOGRAFTS WITH VIRAL IL-10 (vIL-10) PROLONGS SURVIVAL AND ACTS SYNERGISTICALLY WITH CSA IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT HEART ALLOGRAFT REJECTION
DNA-Liposome Versus Adenoviral Gene Transfer of TGFβ1 into Vascularized Cardiac Allografts
Increased pressure for ex vivo transfection of antisense oligodeoxynucleotides in cardiac allografts improves transfection efficiency
VIRAL IL-10 GENE TRANSDUCTION MARKEDLY INHIBITS THE ALLOSTIMULATORY ACTIVITY OF DENDRITIC CELLS.
Complete Reversal of Early Acute Rejection Episodes by Retransplantation of Renal Allografts into Donor Strain Rats Results in a Th1 to Th2 Shift and Prevents the Development of Chronic Rejection
LATE BLOCKADE OF B7-1 COSTIMULATION INTERRUPTS THE DEVELOPMENT OF CHRONIC REJECTION IN A RAT MODEL OF CARDIAC TRANSPLANTATION.
CD40 UPREGULATION IN INFILTRATING CD68+ & TCRα/β+ CELLS AND PARENCHYMAL gp39 (CD40L) INDUCTION ASSOCIATED WITH NF-κB ACTIVATION IN HUMAN CHRONIC RENAL ALLOGRAFT REJECTION
FasL (CD95L) DEFICIENCY AND ITS IMPACT ON THE PATHOGENESIS OF POSTTRANSPLANT ARTERIOSCLEROSIS
BOTH CENTRAL AND PERIPHERAL MECHANISMS PLAY A ROLE IN TOLERANCE INDUCTION AND IN THE PREVENTION OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) IN RECIPIENTS OF HEART/KIDNEY TRANSPLANTS
GRAFT VASCULAR DISEASE (GVD) IN NON HUMAN PRIMATES: QUANTITATION OF CHANGES IN ARTERIAL AUTO- AND ALLOGRAFTS BY INTRAVASCULAR ULTRASOUND (IVUS)
Suppression of the α-1,3-Galactosyl Epitope by Golgi Expression of a Coffee Bean α-1,3-Galactosidase Transgene.
The importance of the Galα1-3Gal antigen in islet xenotransplantation: Immunosuppression that inhibits porcine islet xenograft rejection in Gal+ mice is equally effective in Gal- mice
EXPRESSION OF HUMAN THROMBOMODULIN COFACTOR ACTIVITY IN PORCINE AORTIC ENDOTHELIAL CELLS.
3-Azido-3-Deoxythymidine Decreases Cell Surface Expression of theα-1,3-Galactosyl Carbohydrate on Porcine Endothelial Cells.
DIRECT EVIDENCE THAT B-1 LIKE LYMPHOCYTES PRODUCE XENOREACTIVE ANTIBODIES USING SINGLE-CELL ANALYSIS.
EVIDENCE FOR IgM TO IgG ISOTYPE SWITCHING IN THE HUMORAL RESPONSE TO XENOGRAFTS
INCIDENCE OF INFECTIONS IN CADAVER KIDNEY RECIPIENTS TREATED WITH NEORAL, CELLCEPT, AND PREDNISONE
EFFICACY AND SAFETY OF AMPHOTERICIN B LIPID COMPLEX INJECTION (ABLC) IN SOLID-ORGAN TRANSPLANT RECIPIENTS WITH INVASIVE FUNGAL INFECTIONS
Brain Abscesses in Liver Transplant Recipients: Prospective, Multicenter Study with Implications for Management.
ACCELERATED PROTOCOL OF VACCINATION AGAINST HEPATITIS B PRIOR TO LIVER TRANSPLANTATION
TRANSPLANTATION OF KIDNEYS FROM DONORS WITH HEPATITIS C ANTIBODY INTO HCV RNA POSITIVE RECIPIENTS. A GOOD ALTERNATIVE TO USE THESE ORGANS.
AN OPEN - LABEL PILOT STUDY OF AMANTADINE IN THE TREATMENT OF RECURRENT HEPATITIS C VIRUS (HCV) INFECTION FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION(OLT).
STENOTROPHOMONAS MALTOPHILIA INFECTIONS IN LUNG OR HEART-LUNG TRANSPLANT (LTx) RECIPIENTS.
IMMUNOSUPPRESSION CAUSES REACTIVATION OF EPSTEIN-BARR VIRUS AND EXPANSION OF LATENTLY INFECTED RESTING MEMORY B CELLS BUT NOT TRANSFORMED B BLASTS IN THE PERIPHERAL BLOOD.
A RANDOMIZED PROSPECTIVE TRIAL OF ORAL ACYCLOVIR VS. ORAL GANCICLOVIR FOR CMV PROPHYLAXIS IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS
STABLE LUNG ALLOGRAFT OUTCOME CORRELATES WITH INTRAGRAFT PERSISTENCE OF DONOR-DERIVED LEUKOCYTES.
PLASMA CATECHOLAMINE LEVELS IN END-STAGE LUNG DISEASE: A POTENTIAL MARKER OF DISEASE SEVERITY
OPTIMALIZATION OF IMMUNOSUPPRESSION AFTER PULMONARY TRANSPLANTATION
FIRST PHARMACOKINETIC STUDY WITH SDZ RAD IN STABLE LUNG TRANSPLANT RECIPIENTS
RATES OF CELL CYCLING AND APOPTOSIS AMONG LONG TERM HEART TRANSPLANT SURVIVORS DIFFER FROM NON-TRANSPLANTED INDIVIDUALS
TACROLIMUS AND MMF IN CARDIAC TRANSPLANTATION: IMPORTANCE OF MYCOPHENOLIC ACID DRUG MONITORING
5 YEARS RESULTS OF A PROSPECTIVE RANDOMISED TRIAL COMPARING MONOCLONAL ANTI-CD25 ANTIBODIES VERSUS POLYCLONAL RABBIT ANTITHYMOCYTEGLOBULINE (ATG).
MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY ON EFFICACY AND SAFETY OF MICROEMULSION CYCLOSPORINE VERSUS CONVENTIONAL CYCLOSPORINE IN DE NOVO HEART TRANSPLANT RECIPIENTS: SIX MONTH RESULTS
Basiliximab (Simulect™) is Efficacious in Reducing the Incidence of Acute Rejection Episodes in Renal Allograft Patients: Results at 12 months
Basiliximab (Simulect™) Reduces Acute Cellular Rejection In Renal Allografts From Cadaveric And Living Donors
PRELIMINARY RESULTS OF THE COMBINED USE OF A HUMANIZED ANTI-IL-2Rα MONOCLONAL ANTIBODY, DACLIZUMAB (DZB), AND MYCOPHENOLATE MOFETIL (MMF) WITHOUT CALCINEURIN INHIBITORS IN RENAL TRANSPLANTATION
PHASE II CLINICAL TRIAL WITH DACLIZUMAB (ZENAPAX®) FOR PREVENTION OF ACUTE REJECTION IN LIVER TRANSPLANTED PATIENTS
TACROLIMUS AND MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS: SIX AND TWELVE MONTH RESULTS OF A MULTICENTER, RANDOMIZED DOSE RANGING STUDY
12 MONTH INTENT TO TREAT ANALYSIS OF THE DOUBLE BLIND, RANDOMIZED MULTICENTER THYMOGLOBULIN VS ATGAM TRIAL FOR THE TREATMENT OF ACUTE REJECTION FOLLOWING RENAL TRANSPLANTATION
A PROSPECTIVE RANDOMIZED TRIAL OF NEORAL AND CELLCEPT WITH AND WITHOUT OKT3 INDUCTION
ADULT PRIMARY LIVER TRANSPLANTATION: PROSPECTIVE RANDOMIZE TRIAL OF TACROLIMUS AND STEROID VS TACROLIMUS, STEROID AND MYCOPHENOLATE MOFETIL